aspirin has been researched along with fibrinogen in 296 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 139 (46.96) | 18.7374 |
| 1990's | 53 (17.91) | 18.2507 |
| 2000's | 61 (20.61) | 29.6817 |
| 2010's | 32 (10.81) | 24.3611 |
| 2020's | 11 (3.72) | 2.80 |
| Authors | Studies |
|---|---|
| Damus, PS; Wallace, GA | 1 |
| Kinlough-Rathbone, RL; Mustard, JF; Packham, MA; Perry, DW | 1 |
| Loo, J | 1 |
| Kubisz, P; Suranová, J | 1 |
| Tsukada, T | 1 |
| Ashbrook, PC; Brigden, LP; Didishelm, P; Fine, KM; Maldonado, JE | 1 |
| Alkjaersig, NK; Fletcher, AP; O'Brien, JR; Tulevski, V | 1 |
| Chakrabarti, R; Haines, AP; Meade, TW; North, WR; Stirling, Y | 1 |
| Hanson, SR; Harker, LA | 1 |
| Feinstein, MB; Katz, AJ; Miller, JL | 1 |
| Andreenko, GV; Karabasova, MA; Paramonova, EG; Redziuk, LA; Samsonov, MA | 1 |
| Boneu-Valmalette, A; Bugat, R; Combes, PF; David, JF | 1 |
| Smith, C; Ts'ao, CH | 1 |
| Athanasoulis, CA; DeSanctis, RW; Harris, WH; Salzman, EW; Waltman, AC | 1 |
| Bernard, F; Latour, JG | 1 |
| Jerse, M; Keber, D; Keber, I; Stegnar, M | 1 |
| Jones, RL; Peterson, CM | 1 |
| Glusa, E; Hoffman, A; Markwardt, F; Nowak, G | 1 |
| Bergentz, SE; Hedner, U; Henricsson, A | 1 |
| Bjørnson, J; Brosstad, F | 1 |
| Boisseau, M; Bouloumie, J; Bricaud, H; Broustet, JP; Emeriau, JP | 1 |
| Harker, LA; Ritchie, JL | 1 |
| James, RE; Mammen, EF; Pedersen, HE; Riddle, J; Shier, MR; Wilson, RF | 1 |
| Krugmire, R; Strandness, DE; Ward, K | 1 |
| Alkjaersig, N; Chaplin, H; Fletcher, A; Joist, H | 1 |
| Bachmann, F; Galante, JO; Kaushal, SP; McKenna, R | 1 |
| Kakkar, VV | 1 |
| Dennis, MB; George, CR; Harker, LA; Kenny, GM; Quadracci, LJ; Slichter, SJ; Striker, GE | 1 |
| Clagett, GP; Rosoff, CB; Salzman, EW; Schneider, P | 1 |
| Baxter, CR; Curreri, PW; Wilterdink, ME | 1 |
| Arenson, EB; August, CS | 1 |
| Schwartz, SI; Swedenborg, J | 1 |
| Hosokawa, T; Ikematsu, S; Itoh, O; Samori, T | 1 |
| Amore, C; Cerletti, C; De Curtis, A; de Gaetano, G; Donati, MB; Iacoviello, L; Tacconi, MT | 1 |
| Kelleher, CC | 1 |
| Brash, JL; Cornelius, RM; Garrett, KO; Johnson, PC; Kaplan, SS; Warty, V | 1 |
| Ditter, H; Matthias, FR | 1 |
| Berke, AD; Bovill, EG; Collen, D; Feit, F; Frederick, M; Gore, JM; Hillis, LD; Lambrew, CT; Stump, DC; Terrin, ML | 1 |
| DeCenzo, MT; Kang, J; Saitoh, M; Slayter, HS; Smith, M; Ware, JA; Watkins, SC | 1 |
| Dietrich, M; Hemmer, CJ; Holst, FG; Kern, P; Nawroth, PP | 1 |
| Kinlough-Rathbone, RL; Mustard, JF; Packham, MA; Vickers, JD | 1 |
| Loscalzo, J; Vaughan, DE | 1 |
| Hato, T; Ikeda, K; Kobayashi, Y; Watanabe, A; Yasukawa, M | 1 |
| DeVos-Doyle, K; Lajos, TZ; Stern, MP; Viguera, MG | 1 |
| Bizzi, B; Castagnola, M; De Candia, E; De Cristofaro, R; Di Cera, E; Landolfi, R | 1 |
| Azuma, H; Miura, S; Saito, S; Shigekiyo, T; Uno, Y | 1 |
| Berger, H; Bjornsson, TD; Schneider, DE | 1 |
| Dewanjee, MK; Mashburn, JP; McCarthy, PM; Schaff, HV | 1 |
| Barlow, B; Connellan, JM; Lowe, M; McKenzie, IF; Thurlow, PJ | 1 |
| Banga, HS; Brass, LF; Rittenhouse, SE; Simons, ER | 1 |
| Herold, M; Kogelnig, R; Kunz, F; Zwierzina, WD | 1 |
| Sonoki, H; Sugimoto, T; Tomaru, T; Uchida, Y | 1 |
| Lechner, H; Schmidt, R | 1 |
| Burkel, WE; Graham, LM; Köveker, GB; Stanley, JC; Wakefield, TW | 1 |
| Granack, K; Hamilton, J; Subbarao, V; Ts'ao, C | 1 |
| Damas, J; Remacle-Volon, G | 1 |
| Davies, GC; Goulbourne, IA; Watson, H | 1 |
| Alfaro, MJ; Páramo, JA; Rocha, E | 1 |
| Francis, CW; Marder, VJ; Peerschke, EI | 1 |
| Cerbone, AM; DiMinno, G; Mancini, M; Riccardi, G; Rivellese, A; Silver, MJ | 1 |
| Chandy, T; Sharma, CP | 1 |
| Allen, DG; Crane, S; Johnstone, IB | 1 |
| Hamazaki, T; Hasunuma, K; Kobayashi, S; Shishido, H; Yano, S | 1 |
| Borer, J; Braunwald, E; Chesebro, JH; Cohen, LS; Dalen, J; Dodge, HT; Francis, CK; Hillis, LD; Knatterud, G; Ludbrook, P | 1 |
| Heady, JA; O'Brien, JR; Tulevski, V | 1 |
| Guccione, MA; Jenkins, CS; Mustard, JF; Packham, MA | 1 |
| Bang, NU; Csiscko, BM; Heidenreich, RO; Schroeder, JE; Trygstad, W | 1 |
| Dreyfus, MD; Jenkins, CS; Larrieu, MJ; Meyer, D | 1 |
| Evans, G; Mustard, JF | 1 |
| Farr, RS; Hawkins, D; Pinckard, RN | 1 |
| Quick, AJ | 1 |
| Breddin, K | 1 |
| Kubisz, P | 1 |
| Smit Sibinga, CT | 1 |
| De Gaetano, G; Donati, MB; Vermylen, J | 1 |
| Beys-Col, CD; Masure, R; Moriau, M; Noel, H; Rodhain, J | 1 |
| Crockson, AP; Crockson, RA; McConkey, B; Wilkinson, AR | 1 |
| Görög, P; Kovács, IB | 1 |
| Douglas, AS | 1 |
| Jenkins, CS; Kinlough-Rathbone, RL; Mustard, JF; Packham, MA | 1 |
| Bennert, C; Berger, E; Jäger, W; Kauschmann, R; Kutschera, J; Pietsch, U; Riese, W; Wendeberg, H | 1 |
| Kirby, RE; Lassman, HB; Novick, WJ | 1 |
| George, JN | 1 |
| Lyon, LJ; Nevins, MA | 1 |
| O'Brien, JR | 2 |
| Beller, FK; Slabber, CF; Theiss, W | 1 |
| George, CR; Harker, LA; Quadracci, LJ; Slichter, SJ; Striker, GE | 1 |
| Duckert, F | 1 |
| Bergentz, SE | 2 |
| Didisheim, P; Fuster, V; Kazmier, FJ | 1 |
| Gallus, AS; Hirsh, J | 1 |
| Hilgard, P; Hohage, R; Minne, H; Schmitt, W; Ziegler, R | 1 |
| Cronberg, S | 1 |
| Penner, JA; Schnetzer, GW | 1 |
| Butterfield, WJ; O'Brien, JR | 1 |
| Duckert, F; Marbet, GA | 1 |
| Chisholm, GM; Gainer, JL | 1 |
| McGrouther, DA; McNicol, GP; Prentice, CR; Sinclair, J; Wood, EH | 1 |
| Jaffe, EA; Merskey, C; Nachman, RL | 1 |
| O'Sullivan, EF; Renney, JT | 1 |
| Grant, RA; Zucker, MB | 1 |
| Alkjaersig, N; Etherington, M; Fletcher, A; Madgwick, T; O'Brien, JR; Tulevski, VG | 1 |
| Johnsson, H; Niklasson, PM | 1 |
| Arrington, PJ; McNamara, JJ | 1 |
| Harker, LA; Slichter, SJ | 2 |
| Ardlie, NG; Han, P | 1 |
| Hampton, JW | 1 |
| Berberich, FR; Chard, RL; Cuene, SA; Hartmann, JR | 1 |
| Cash, JD; Clarkson, AR; MacDonald, MK; Robson, JS | 1 |
| Barr, RD; Douglas, AS; Forbes, CD; McNicol, GP | 1 |
| Bonardi, G; Coppi, G | 1 |
| Abelseth, MK; Debbie, JG | 1 |
| Bergentz, SE; Lewis, D; Ljungqvist, U | 1 |
| Larrieu, MJ | 1 |
| Rådegran, K | 1 |
| Attar, S; Raskin, HF; Toskes, PP; Wagger, GM | 1 |
| Kubisz, P; Larrieu, MJ; Rigollot, C | 1 |
| Cronberg, S; Kubisz, P | 1 |
| Casteels-Van Daele, M; De Gaetano, G | 1 |
| Rogers, J; Weiss, HJ | 1 |
| Briazgunov, IP | 1 |
| Borow, M; Goldson, H | 1 |
| Lowe, LW | 1 |
| Morales, OI; Vara-Thorbeck, R | 1 |
| Barbieri, B; Bertelé, V; Bianchi, L; Cerletti, C; de Gaetano, G; Dejana, E; di Minno, G; Silver, MJ | 1 |
| Bennett, JS; Burch, JW; Vilaire, G | 1 |
| Barrett, JT; Campbell, BJ; Forrester, LJ; Kurpiewski, GE | 1 |
| Edwards, RL; Rickles, FR | 1 |
| Agam, G; Livne, A; Shohat, O | 1 |
| Agam, G; Livne, A | 2 |
| Cohen, I; Glueck, R; Green, D; Ts'ao, CH | 1 |
| Furukawa, Y; Kondo, M; Murakami, M; Takemura, S; Yoshikawa, T | 1 |
| Alkjaersig, N; Chaplin, H; Fletcher, AP; Joist, JH; Michael, JM | 1 |
| Neumann, K; Schemper, M; Zekert, F | 1 |
| Patscheke, H | 1 |
| Dormandy, JA | 1 |
| Lindenauer, SM; Penner, JA; Schultz, JS | 1 |
| Abiko, Y; Ashida, S; Sakuma, K | 1 |
| Clagett, GP; Hufnagel, H; Russo, M | 1 |
| Abe, H; Kuroiwa, A; Nakashima, Y; Takahara, K | 1 |
| Baeza, E; Boulard, C; Delers, F; Poitou, I | 1 |
| Buller, NP; Chronos, NA; Goodall, AH; Hutton, RA; Janes, SL; Wilson, DJ | 1 |
| Labrunie, P; Lévy, G; Lévy, PY; Teysseire, N; Valeix, B | 1 |
| Davies, JA; Goodfield, MJ; Ibbotson, SH; Layton, AM | 1 |
| Oda, M; Yamamoto, N; Yamashita, A; Yokota, K | 1 |
| Greinacher, A; Lasser, R; Reininger, AJ; Reininger, CB; Schweiberer, L; Steckmeier, B | 1 |
| Crawford, GP; Gibbs, NM; Michalopoulos, N | 1 |
| Hirvonen, M; Kala, R; Krusius, T; Vahtera, E | 1 |
| Meade, TW | 1 |
| Badimon, JJ; Badimon, L; Chesebro, JH; Fernández-Ortiz, A; Fuster, V; Mailhac, A; Meyer, BJ | 1 |
| Chiba, K; Sasaki, K; Suzuki, H; Takahashi, H; Tamura, K; Tohgi, H | 1 |
| Fukuyama, M; Handa, M; Ikeda, Y; Itagaki, I; Maruyama, S; Uchiyama, S; Yamazaki, M | 1 |
| Kashiwaya, M; Takahashi, H; Tohgi, H; Watanabe, K | 1 |
| Bozarth, JM; Forsythe, MS; Mousa, SA; Reilly, TM | 1 |
| Campbell, S; Gunn, J; Rowlands, L; Trudgill, NJ; Tsikaderis, D; Violaris, AG | 1 |
| Bovill, EG; Burns, SL; Byers, PH; Golden, EA; Grenko, RT | 1 |
| Barsan, W; Broderick, JP; Brott, TG; Haley, EC; Levy, DE; Marler, JR; Sheppard, GL | 1 |
| Beretz, A; Cazenave, JP; Freund, M; Gachet, C; Mantz, F; Meyer, L; Mulvihill, J; Nicolini, P | 1 |
| Gabriel, DA; Li, X; Muga, KM; Reece, NS; Witte, JH | 1 |
| Feijge, MA; Heemskerk, JW; Hoyland, J; Mason, WT; Sage, SO; Vis, P | 1 |
| Chiba, K; Takahashi, H; Tamura, K; Tohgi, H | 1 |
| Gawaz, M; May, A; Mössmer, G; Neumann, FJ; Ott, I; Schömig, A | 1 |
| Bihour, C; Nurden, AT; Nurden, P; Raymond, JM; Smith, M | 1 |
| Gawaz, M; May, A; Neumann, FJ; Ott, I; Schömig, A | 1 |
| Arrigoni, L; Muggiasca, ML; Pagliaro, P; Poggio, M; Rossi, E; Russo, U | 1 |
| Fukuuchi, Y; Kobari, M; Takeda, H; Tanahashi, N; Tomita, M; Yokoyama, M | 1 |
| Droste, DW; Kaps, M; Siemens, HJ; Sonne, M; Wagner, T | 1 |
| Evanson, OA; Weiss, DJ; Wells, RE | 1 |
| Aulesa, C; Ortega, JJ; Petit, M; Sentis, M | 1 |
| Jørgensen, L; Klementsen, B | 1 |
| Feijge, MA; Heemskerk, JW; Lindhout, T; Reutelingsperger, CP; Vuist, WM | 1 |
| Byrne, A; Crean, P; Fitzgerald, DJ; Maher, M; Moran, N; Walsh, N | 1 |
| Mohammad, SF; Sogawa, M | 1 |
| Borkowski, U; Darius, H; Genth, S; Meyer, J; Nowak, B; Rupprecht, HJ; Voigtländer, T | 1 |
| Aoki, T; Honda, S; Okubo, M; Seki, J; Senzaki, K; Takahashi, F; Takasugi, H; Tanaka, A; Tomiyama, Y | 1 |
| Arnout, J; Pislaru, C; Pislaru, S; Szilard, M; Van de Werf, F | 1 |
| Bode, C; Kohler, B; Kübler, W; Moser, M; Nordt, T; Peter, K; Salbach, P; Schwarz, M; Ylänne, J | 1 |
| Dickfeld, T; Gawaz, M; Neumann, FJ; Pogátsa-Murray, G; Ruf, A; Schömig, A; Zohlnhöfer, D | 1 |
| Hennekens, CH; Ma, J; Ridker, PM; Stampfer, MJ | 1 |
| Holmes, MB; Howard, DB; Schneider, DJ; Sobel, BE | 1 |
| Dzirlo, L; Eichler, HG; Hollenstein, U; Jilma, B; Kapiotis, S; Pernerstorfer, T; Speiser, W; Stohlawetz, P | 1 |
| Bovill, EG; Cornell, ES; Cushman, M; Feinberg, WM; Hart, RG; Lip, GY; Pearce, LA | 1 |
| Cibulova, L; Fedelesova, V; Gajdos, M; Huttova, D; Krivosikova, Z; Mongiellova, V; Polak, F | 1 |
| Barnard, MR; Bray, PF; Christie, DJ; Coleman, L; Furman, MI; Goldschmidt-Clermont, P; Hamlington, J; Hendrix, C; Kickler, T; Kundu, S; Mascelli, MA; Michelson, AD | 1 |
| Breddin, HK; Graff, J; Harder, S; Kirchmaier, CM; Klinkhardt, U; Mahnel, R; Westrup, D | 1 |
| Blann, AD; Li-Saw-Hee, FL; Lip, GY | 1 |
| Jagroop, IA; Mikhailidis, DP; Milionis, HJ | 1 |
| Aguejouf, O; Belon, P; Doutremepuich, C; Malfatti, E | 1 |
| Bozarth, J; Confalone, PN; Forsythe, M; Jin, F; Mousa, SA | 1 |
| Badimon, JJ; Chesebro, JH; Farkouh, ME; Fuster, V; Helft, G; Lev, EI; Osende, JI; Rodriguez, OJ; Worthley, SG; Zaman, AG | 1 |
| Droullé, C; Garnotel, R; Hézard, N; Metz, D; Nguyen, P; Potron, G | 1 |
| Baumann, PQ; Holmes, MB; Schneider, DJ; Sobel, BE; Taatjes, DJ | 1 |
| Clemetson, JM; Clemetson, KJ; Dörmann, D; Navdaev, A | 1 |
| Clement, DL; De Buyzere, M; Delanghe, J; Duprez, D; Langlois, M | 1 |
| Eto, K; Goto, S; Handa, S; Ikeda, Y; Isshiki, T; Ochiai, M; Sato, T; Takeshita, S; Terakura, M | 1 |
| Campeau, L; Forman, S; Fox, NL; Herd, JA; Hickey, A; Hoogwerf, BJ; Hoppensteadt, D; Hunninghake, DB; Pifarré, R; Probstfield, JL; Terrin, ML; Walenga, JM | 1 |
| Chew, DP; Moliterno, DJ; Mukherjee, D; Raymond, RE; Robbins, M; Yadav, JS | 1 |
| Blombäck, M; He, S; Henschen-Edman, AH; Sinha, R; Yoo, G | 1 |
| Brummel, K; Mann, KG; Musial, J; Szczeklik, A; Undas, A | 2 |
| Hunt, BJ; Kelly, J; Lewis, RR; Rudd, A | 1 |
| Cibulová, L; Dzúrik, R; Gajdos, M; Huttová, D; Krivosíková, Z; Mongiellová, V; Spustová, V | 1 |
| Iwata, M; Uchiyama, S; Yamazaki, M | 1 |
| Bang, NU; Biller, J; Bruno, A; Cheryk, LA; Durocher, A; Fleck, JD; McConnell, JP; Meschia, JF; Williams, L | 1 |
| Frelinger, AL; Furman, MI; Jakubowski, JA; Jordan, RE; Marchese, PJ; Marciniak, SJ; Mascelli, MA; Michelson, AD | 1 |
| Barshtein, G; Ben-Ami, R; Berliner, AS; Eldor, A; Roth, A; Sheinman, G; Yedgar, S | 1 |
| Iturbe, T; Moreno, JA; Recaséns, Mdel V; Romero, MS | 1 |
| Tracy, RP | 1 |
| Goncalves, I; Hughan, SC; Jackson, SP; Schoenwaelder, SM; Yap, CL; Yuan, Y | 1 |
| REID, J; SPROULL, DH | 1 |
| MURDOCH, WR; WILL, G | 1 |
| Bal dit Sollier, C; Choussat, R; Collet, JP; Dalby, M; Drobinski, G; Drouet, L; Gallois, V; Montalescot, G; Soulat, T; Thomas, D; Vicaut, E | 1 |
| Joshipura, KJ; Merchant, AT; Rimm, EB; Wand, HC | 1 |
| Grübler, B | 1 |
| Aseichev, AV; Azizova, OA | 1 |
| Chesebro, JH; Grill, DE; Hassinger, NL; McBane, RD | 1 |
| Bachoo, P; Brittenden, J; Cassar, K; Ford, I; Greaves, M | 1 |
| Oliveira, GH | 1 |
| James, SK; Johnston, N; Lindbäck, J; Oldgren, J; Siegbahn, A; Wallentin, L | 1 |
| Gao, X; Han, F; Liu, X; Yang, X; Yao, W | 1 |
| Antovic, A; Blombäck, M; Ekman, GJ; He, S; Hjemdahl, P; Perneby, C; Wallen, HN | 1 |
| Aguejouf, O; Belon, P; Doutremepuich, C; Eizayaga, FX | 1 |
| Alkonyi, B; Czopf, L; Feher, G; Kenyeres, P; Kesmarky, G; Koltai, K; Papp, E; Solyom, A; Toth, K | 1 |
| Alström, U; Oldgren, J; Siegbahn, A; Ståhle, E; Tydén, H | 1 |
| Burner, JD; Dyszkiewicz-Korpanty, AM; Frenkel, EP; Kim, A; Sarode, R | 1 |
| Badimon, JJ; Choi, BG; Fuster, V; Vilahur, G; Viles-Gonzalez, JF; Vorchheimer, DA; Zafar, MU | 1 |
| Cawich, I; Chen, J; Dandapat, A; Deonikar, P; Hu, CP; Kavdia, M; Marwali, MR; Mehta, JL; Mohandas, B; Sawamura, T | 1 |
| Bachoo, P; Brittenden, J; Croal, B; Ford, I; Greaves, M; Hillis, GS; Rajagopalan, S | 1 |
| Duke, PG; Guyton, RA; Levy, JH; Puskas, JD; Tanaka, KA; Thourani, VH; Williams, WH | 1 |
| Bliden, KP; Chaganti, SK; Dichiara, J; Gesheff, TB; Gurbel, PA; Kreutz, RP; Kreutz, Y; Tantry, US | 1 |
| Badimon, L; Casaní, L; Vilahur, G | 1 |
| Buryachkovskaya, LI; Kadinskaya, MI; Khaspekova, SG; Mazurov, AV; Shvartsman, AL; Sirotkina, OV; Sivachenko, EB; Taraskina, AE; Uchitel', IA; Vavilova, TV; Zabotina, AM; Zueva, EE | 1 |
| Feher, G; Kesmarky, G; Koltai, K; Toth, K | 1 |
| Cung, T; Fischer, JE; Haeberli, A; Helfricht, S; Kudielka, BM; Metzenthin, P; Preckel, D; von Känel, R | 1 |
| Gao, L; Liu, Q; Wang, PP | 1 |
| Gaal, V; Juricskay, I; Kesmarky, G; Koltai, K; Toth, A; Vekasi, J | 1 |
| Rudzevich, AJ; Shapovalova, EM | 1 |
| Liu, Y; Liu, YF; Yan, FF; Zhao, YX | 1 |
| Dolgikh, VT; Faĭl', IL; Kireeva, NV; Kovaleva, SV; Morova, NA; Smirnov, DE | 1 |
| Hashimoto, A; Nishikawa, M; Ohashi, K; Okuda, M; Onoda, K; Shimono, T; Shimpo, H | 1 |
| Hall, JK | 1 |
| Alexy, T; Feher, G; Horvath, B; Kenyeres, P; Kesmarky, G; Koltai, K; Lenart, I; Marton, Z; Toth, K | 1 |
| Bark, N; Blombäck, M; He, S; Svensson, J; Wang, H | 1 |
| Ajjan, RA; Ariëns, RA; Gersh, KC; Grant, PJ; Kearney, MT; Khanbhai, M; Phoenix, F; Standeven, KF; Weisel, JW | 1 |
| Eriksson, AC; Hedbäck, B; Jonasson, L; Lindahl, TL; Whiss, PA | 1 |
| Deary, IJ; Fowkes, FG; Lowe, GD; Marioni, RE; Murray, GD; Price, JF; Rumley, A; Stewart, MC | 1 |
| Ak, K; Arsan, S; Eksioglu-Demiralp, E; Iqbal, O; Isbir, S; Tetik, S; Yardimci, T | 1 |
| Bett, N; Juneja, M; Ray, MJ; Walters, DL | 1 |
| Dong, JF; Guthikonda, S; Kleiman, NS; Mangalpally, KK; Siqueiros-Garcia, A; Vaduganathan, M | 1 |
| Hanke, A; Posch, A; Schöchl, H; Solomon, C; Voelckel, W | 1 |
| Chen, Y; Huang, J; Liu, G; Liu, X; Lu, N; Xu, Y; Yang, D | 1 |
| Bernlochner, I; Braun, S; Jaitner, J; Kastrati, A; Mehilli, J; Morath, T; Schömig, A; Sibbing, D; Stegherr, J; Steinhubl, S; von Beckerath, N | 1 |
| Heinemann, A; Konya, V; Lippe, IT; Marsche, G; Peskar, BA; Philipose, S; Schuligoi, R; Sreckovic, I | 1 |
| Deary, IJ; Fowkes, FG; Gow, AJ; Harris, SE; Houlihan, LM; Lowe, GD; Luciano, M; Marioni, RE; Murray, GD; Price, JF; Rumley, A; Stewart, MC; Strachan, MW | 1 |
| Cheng, YS; Li, MH; Liu, F; Tan, HQ; Wang, J; Wang, JB; Zhao, JG; Zhu, YQ | 1 |
| Alexandrov, AV; Barreto, AD | 1 |
| Adamson, U; Bergman, AC; Blombäck, M; Jörneskog, G; Svensson, J; Wallén, H | 1 |
| Doğan, A; Erdogan, D; Icli, A; Varol, E | 1 |
| Grant, DC; O'Kell, AL; Panciera, DL; Troy, GC; Weinstein, NM | 1 |
| Chen, SY; Chiang, YY; Ho, YP; Hsu, HY; Lai, PT; Lee, YS | 1 |
| Conyers, JL; Dong, JF; Fu, Y; Li, M; Liu, L; Liu, X; Yang, X; Zaske, AM; Zhang, J; Zhang, Y; Zhou, Z | 1 |
| Chełstowski, K; Clark, J; Jastrzębska, M; Nowacki, P; Siennicka, A; Wódecka, A | 1 |
| Bakirci, EM; Borekci, A; Kalkan, K; Karakoyun, S; Sevimli, S; Topcu, S; Vançelik, S | 1 |
| Klimenkova, VF; Tiutrin, II; Udut, VV | 1 |
| Alexy, T; Feher, G; Kenyeres, P; Kesmarky, G; Koltai, K; Marton, Z; Papp, J; Tibold, A; Toth, K | 1 |
| Achuthan, S; Ahluwalia, J; Bhalla, A; Chandurkar, N; Malhotra, S; Pareek, A; Shafiq, N | 1 |
| Ajjan, RA; Grant, PJ; Grove, EL; Hvas, AM; Kristensen, SD; Kurdee, Z; Larsen, SB; Neergaard-Petersen, S; Phoenix, F | 1 |
| Amsallem, M; Bal dit Sollier, C; Dillinger, JG; Drouet, L; Henry, P; Manzo-Silberman, S; Sideris, G; Voicu, S | 1 |
| Brown, MR; D'Silva, L; Davidson, SJ; Evans, PA; Evans, V; Hawkins, K; Lawrence, M; Morris, RH; Potter, JF; Sabra, A; Stanford, SN; Storton, S; Wani, M; Williams, PR | 1 |
| Garbacz, M; Kaczmarski, J; Kuliczkowski, W; Pacholewicz, J; Serebruany, V; Zakliczyński, M; Zembala, M | 1 |
| Calò, PG; Erdas, E; Furcas, S; Medas, F; Nicolosi, A; Pisano, G; Podda, F | 1 |
| de Borst, GJ; Moll, FL; Roest, M; Teraa, M; Verhaar, MC; Wisman, PP | 1 |
| Li, JY; Liu, GR; Liu, XW; Ma, N; Mohamed, I; Yang, YJ; Zhang, JY | 1 |
| Biolik, G; Kokot, M; Pawlicki, K; Święszek, A; Sznapka, M; Ziaja, D; Ziaja, K | 1 |
| Auque, H; Berard, X; Carrie, C; Freyburger, G; Labrouche, S; Roullet, S | 1 |
| Aleksic, N; Babic, S; Calija, B; Gajin, P; Ilijevski, N; Maravic-Stojkovic, V; Matic, P; Nenezic, D; Popov, P; Radak, D; Rancic, Z; Tanaskovic, S; Vasic, D; Vucurevic, G | 1 |
| Jung, JM; Kim, SU; Kwon, DY; Park, JW; Park, MH | 1 |
| Canino, J; Canobbio, I; Guidetti, GF; Torti, M; Visconte, C; Zarà, M | 1 |
| Bouvier, S; Chea, M; de Mazancourt, P; Gris, JC; Hanss, M; Ripart, S | 1 |
| Augello, AF; Carloni, S; De Matteis, S; Fattori, PP; Ghetti, M; Giordano, G; Lucchesi, A; Martinelli, G; Musuraca, G; Napolitano, R; Poggiaspalla, M | 1 |
| Alvarez-Roman, MT; De la Corte-Rodriguez, H; Jimenez-Yuste, V; Martin-Salces, M; Rodriguez-Merchan, EC | 1 |
| Gao, D; Li, L; Li, RS; Liu, ZJ; Niu, M; Wang, JB; Wu, SN; Xiao, XH; Zhang, CE; Zhang, L | 1 |
| Bärnthaler, T; Buschmann, E; Heinemann, A; Mahla, E; Prüller, F; Schuligoi, R; Toth, GG | 1 |
| Estep, J; Hodges, K; Hsich, E; Insler, J; Insler, S; Mubashir, M; Soltesz, E; Tong, M | 1 |
| Cancelas, JA; Hegde, S; Wellendorf, AM; Zheng, Y | 1 |
| Bryk, AH; Undas, A; Wiśniewski, JR; Zettl, K | 1 |
| Altmann, R; Baschin, M; Kohlmann, T; Marx, S; Paland, H; Rauch, B; Schroeder, HWS | 1 |
| Li, X; Lv, Q; Wang, Z; Xu, S; Yao, Y | 1 |
| Chen, D; Gao, X; He, C; Huan, X; Huang, X; Li, Y; Liu, L; Zhang, T | 1 |
| Goethe, EA; Heimberger, AB; Rao, G | 1 |
20 review(s) available for aspirin and fibrinogen
| Article | Year |
|---|---|
Deep vein thrombosis. Detection and prevention.
Topics: Administration, Oral; Anticoagulants; Aspirin; Dextrans; Dipyridamole; Female; Fibrinogen; Heparin; Humans; Infusions, Parenteral; Injections, Subcutaneous; Iodine Radioisotopes; Male; Phlebography; Plethysmography, Impedance; Postoperative Complications; Thrombophlebitis; Ultrasonography; Venous Insufficiency; Wounds and Injuries | 1975 |
Plasma fibrinogen and factor VII as risk factors for cardiovascular disease.
Topics: Aged; Aspirin; Blood Coagulation; Coronary Thrombosis; Dietary Fats; Drug Therapy, Combination; Factor VII; Fibrinogen; Humans; Intracranial Embolism and Thrombosis; Male; Middle Aged; Risk Factors; Smoking; Warfarin | 1992 |
Hemostasis in surgical procedures.
Topics: Acetylcholine; Antimetabolites; Aspirin; Autonomic Nervous System; Blood Circulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Calcium; Cell Aggregation; Clot Retraction; Dicumarol; Epinephrine; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Fibrin; Fibrinogen; Hemorrhage; Hemostasis; Humans; Prothrombin; Prothrombin Time; Surgical Procedures, Operative; Thrombin; Vasoconstrictor Agents; Vasodilator Agents; Vitamin K | 1969 |
Management of thrombotic diseases.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Coumarins; Dextrans; Dipyridamole; Drug Antagonism; Drug Hypersensitivity; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Heart Valve Prosthesis; Hemorrhage; Heparin; Histamine H1 Antagonists; Humans; Hydrocortisone; Indenes; Intracranial Embolism and Thrombosis; Iodine Isotopes; Platelet Adhesiveness; Prostaglandins; Reserpine; Rheumatic Heart Disease; Streptokinase; Sulfinpyrazone; Thrombosis | 1971 |
Prevention of thromboembolism after hip fracture.
Topics: Aged; Anticoagulants; Aspirin; Bandages; Coumarins; Dextrans; Exercise Therapy; Femoral Neck Fractures; Fibrinogen; Fractures, Bone; Hemorrhage; Hip Injuries; Humans; Iodine Isotopes; Physical Exertion; Postoperative Care; Postoperative Complications; Pulmonary Embolism; Thromboembolism; Thrombophlebitis; Warfarin | 1973 |
The mechanisms of venous thrombosis. Anticoagulants, aspirin, and heparin.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Blood Coagulation Tests; Fibrinogen; Heparin; Humans; Injections, Intradermal; Iodine Radioisotopes; Platelet Adhesiveness; Thrombophlebitis | 1973 |
Thromboembolism. Diagnosis and treatment.
Topics: Adult; Aspirin; Dipyridamole; Femoral Vein; Fibrinogen; Heparin; Humans; Iliac Vein; Iodine Radioisotopes; Methods; Phlebography; Plethysmography, Impedance; Postoperative Complications; Radionuclide Imaging; Thromboembolism; Thrombophlebitis; Ultrasonography | 1974 |
[New possibilities for the prophylaxis of postoperative acute deep thrombophlebitis].
Topics: Administration, Oral; Anticoagulants; Ascorbic Acid; Aspirin; Dextrans; Ethylestrenol; Fibrinogen; Heparin; Humans; Iodine Radioisotopes; Phenformin; Postoperative Complications; Thrombophlebitis | 1974 |
Septic shock and disturbances in coagulation.
Topics: Acidosis; Acute Kidney Injury; Aminocaproates; Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Cardiac Output; Cyclohexanecarboxylic Acids; Disseminated Intravascular Coagulation; Fibrinogen; Fibrinolysis; Gastrointestinal Hemorrhage; Humans; Hypoxia; Lung Diseases; Methylamines; Respiratory Insufficiency; Shock, Septic; Transfusion Reaction | 1974 |
Platelet inhibition in the management of thrombosis.
Topics: Aspirin; Blindness; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Dextrans; Dipyridamole; Fibrinogen; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Iodine Radioisotopes; Molecular Weight; Myocardial Infarction; Phlebography; Renal Dialysis; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Thrombosis | 1974 |
The diagnosis and prevention of post operative venous thrombosis.
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Platelets; Depression, Chemical; Dextrans; Fibrinogen; Fibrinolysis; Hemorrhage; Hemostasis; Heparin; Humans; Iodine Radioisotopes; Physical Examination; Plethysmography, Impedance; Postoperative Complications; Pulmonary Embolism; Radionuclide Imaging; Thrombophlebitis; Ultrasonography | 1973 |
Venous thrombosis and embolism.
Topics: Angiography; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Auscultation; Blood Coagulation; Blood Coagulation Tests; Blood Viscosity; Dextrans; Endothelium; Fibrinogen; Fibrinolysis; Heparin; Humans; Iodine Radioisotopes; Phlebography; Platelet Aggregation; Rheology; Thrombophlebitis; Thrombosis | 1981 |
Haemostatic function, arterial disease and the prevention of arterial thrombosis.
Topics: Adult; Aged; Anticoagulants; Arteries; Aspirin; Blood Coagulation Factors; Cardiovascular Diseases; Case-Control Studies; Clinical Trials as Topic; Factor VII; Factor VIII; Female; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemophilia A; Hemostasis; Humans; Male; Middle Aged; Models, Biological; Models, Cardiovascular; Prospective Studies; Regression Analysis; Risk Factors; Thrombosis | 1994 |
[Platelet-leukocyte interactions in coronary heart disease: pathophysiology, clinical relevance, pharmacological modulation].
Topics: Abciximab; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Blood Platelets; CD18 Antigens; Chemotaxis, Leukocyte; Coronary Artery Bypass; Coronary Disease; Cytokines; Fibrinogen; Heparin; Humans; Immunoglobulin Fab Fragments; Leukocytes; Ligands; Macrophage-1 Antigen; Membrane Glycoproteins; Models, Biological; Myocardial Infarction; Neutrophils; P-Selectin; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombospondins; Tirofiban; Tyrosine | 2000 |
Screening for subclinical deep-vein thrombosis.
Topics: Anticoagulants; Aspirin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Heparin; Humans; Magnetic Resonance Imaging; Patient Selection; Plethysmography; Venous Thrombosis | 2001 |
Inflammation, the metabolic syndrome and cardiovascular risk.
Topics: Arteriosclerosis; Aspirin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Estrogens; Female; Fibrinogen; Humans; Hypolipidemic Agents; Male; Metabolic Syndrome; Risk Factors | 2003 |
Novel serologic markers of cardiovascular risk.
Topics: Antioxidants; Aspirin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cause of Death; Cytokines; Drug Resistance; Fibrinogen; Homocysteine; Humans; Platelet Aggregation Inhibitors; Risk Factors; Survival Rate | 2005 |
Giant-cell arteritis.
Topics: Aspirin; Blood Sedimentation; C-Reactive Protein; Fibrinogen; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Interleukin-6; Magnetic Resonance Angiography; Methotrexate; Platelet Count; Radiopharmaceuticals; Ultrasonography, Doppler, Color | 2008 |
Adjunctive and alternative approaches to current reperfusion therapy.
Topics: Aspirin; Electric Stimulation Therapy; Endovascular Procedures; Fibrinogen; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Reperfusion Injury; Stroke; Thrombin; Thrombolytic Therapy; Tomography, X-Ray Computed; Ultrasonic Therapy | 2012 |
'Do not Do' Recommendations in Hemophilia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Coagulation Factors; Deamino Arginine Vasopressin; Disease Management; Exercise; Factor VIII; Fibrinogen; Hemarthrosis; Hemophilia A; Hemostatics; Humans; Practice Guidelines as Topic | 2020 |
58 trial(s) available for aspirin and fibrinogen
| Article | Year |
|---|---|
[Possibilities and limits of controlled clinical therapy studies for the demonstration of the effectiveness of antithrombotic therapy].
Topics: Adult; Anticoagulants; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy; Early Ambulation; Exercise Therapy; Fibrinogen; Fibrinolysis; Heparin; Humans; Myocardial Infarction; Physical Therapy Modalities; Platelet Aggregation; Postoperative Complications; Posture; Pulmonary Embolism; Streptokinase; Sulfinpyrazone; Thromboembolism; Thrombosis | 1975 |
Aspirin and plasma-fibrinogen.
Topics: Adult; Aspirin; Clinical Trials as Topic; Female; Fibrinogen; Humans; Male; Middle Aged; Sex Factors | 1977 |
Aspirin prophylaxis of venous thromboembolism after total hip replacement.
Topics: Adult; Aspirin; Clinical Trials as Topic; Female; Fibrinogen; Hip Joint; Humans; Joint Prosthesis; Male; Middle Aged; Phlebography; Postoperative Complications; Pulmonary Embolism; Sex Factors; Thrombophlebitis | 1977 |
The influence of combined treatment with propranolol and acetylsalicylic acid on platelet aggregation in coronary heart disease.
Topics: Adult; Aspirin; Clinical Trials as Topic; Coronary Disease; Drug Interactions; Epinephrine; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Propranolol; Time Factors | 1979 |
Fat embolism prophylaxis: a study of four treatment modalities.
Topics: Adolescent; Adult; Aspirin; Blood Platelets; Carbon Dioxide; Dextrans; Embolism, Fat; Factor V; Fibrinogen; Fractures, Bone; Glucose Solution, Hypertonic; Humans; Infusions, Parenteral; Methylprednisolone; Middle Aged; Oxygen | 1977 |
The influence of aspirin on postoperative platelet kinetics and venous thrombosis.
Topics: Adult; Aged; Aspirin; Blood Cell Count; Blood Platelets; Cell Survival; Chromium Radioisotopes; Female; Fibrinogen; Humans; Hydroxyindoleacetic Acid; Iodine Radioisotopes; Kinetics; Male; Middle Aged; Phlebography; Postoperative Complications; Thrombophlebitis | 1975 |
Characterization of elevated fibrin split products following thermal injury.
Topics: Aspirin; Burns; Disseminated Intravascular Coagulation; Drug Evaluation; Fibrin; Fibrinogen; Hemagglutination Inhibition Tests; Heparin; Humans; Immunoassay; Prospective Studies; Staphylococcus | 1975 |
Modulation of fibrinolytic response to venous occlusion in humans by a combination of low-dose aspirin and n-3 polyunsaturated fatty acids.
Topics: Adult; Aspirin; Blood Platelets; Cell Membrane; Double-Blind Method; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Female; Fibrinogen; Fibrinolysis; Humans; Male; Plasminogen Activator Inhibitor 1; Protein S; Tissue Plasminogen Activator; Venous Insufficiency | 1992 |
Plasma fibrinogen and factor VII as risk factors for cardiovascular disease.
Topics: Aged; Aspirin; Blood Coagulation; Coronary Thrombosis; Dietary Fats; Drug Therapy, Combination; Factor VII; Fibrinogen; Humans; Intracranial Embolism and Thrombosis; Male; Middle Aged; Risk Factors; Smoking; Warfarin | 1992 |
Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.
Topics: Aspirin; Coronary Artery Bypass; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Heparin; Humans; Male; Metoprolol; Myocardial Infarction; Plasminogen; Recombinant Proteins; Statistics as Topic; Thrombolytic Therapy; Tissue Plasminogen Activator | 1991 |
Neither heparin nor acetylsalicylic acid influence the clinical course in human Plasmodium falciparum malaria: a prospective randomized study.
Topics: Aspirin; Fibrinogen; Heparin; Humans; L-Lactate Dehydrogenase; Malaria, Falciparum; Partial Thromboplastin Time; Platelet Count; Prospective Studies; Prothrombin Time; Tumor Necrosis Factor-alpha | 1991 |
Effect of aspirin on postoperative venous thrombosis. Report of the Steering Committee of a trial sponsored by the Medical Research Council.
Topics: Adult; Age Factors; Aspirin; Blood Group Antigens; Blood Platelets; Clinical Trials as Topic; Female; Fibrinogen; Hemostasis; Humans; Iodine Radioisotopes; Male; Methods; Middle Aged; Placebos; Postoperative Complications; Sex Factors; Thrombophlebitis; Time Factors | 1972 |
Trial of aspirin and RA 233 in prevention of post-operative deep vein thrombosis.
Topics: Aspirin; Dipyridamole; Femoral Neck Fractures; Fibrinogen; Humans; Iodine Radioisotopes; Placebos; Postoperative Complications; Thrombophlebitis; Time Factors | 1973 |
Platelet function studies before and after operation and the effect of postoperative thrombosis.
Topics: Adenosine Diphosphate; Adult; Aged; Aspirin; Blood Cell Count; Blood Platelets; Chromatography; Collagen; Epinephrine; Female; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Male; Middle Aged; Neoplasms; Placebos; Platelet Adhesiveness; Postoperative Complications; Radionuclide Imaging; Surgical Procedures, Operative; Thrombin; Thrombosis | 1974 |
Modification by drugs of urinary fibrin/fibrinogen degradation products in glomerulonephritis.
Topics: Adolescent; Adult; Aged; Aspirin; Child; Creatinine; Female; Fibrin; Fibrinogen; Glomerulonephritis; Humans; Indomethacin; Kidney Glomerulus; Male; Middle Aged; Plasminogen; Prednisone; Proteinuria; Time Factors; Urea | 1972 |
Anti-inflammatory drugs and the prevention of thrombosis.
Topics: Analgesics; Aspirin; Blood Coagulation; Cell Membrane; Female; Fibrinogen; Humans; Iodine Isotopes; Male; Placebos; Platelet Adhesiveness; Sex Factors; Thrombosis | 1971 |
Venous thrombosis and embolism.
Topics: Angiography; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Auscultation; Blood Coagulation; Blood Coagulation Tests; Blood Viscosity; Dextrans; Endothelium; Fibrinogen; Fibrinolysis; Heparin; Humans; Iodine Radioisotopes; Phlebography; Platelet Aggregation; Rheology; Thrombophlebitis; Thrombosis | 1981 |
Aspirin-dipyridamole prophylaxis of sickle cell disease pain crises.
Topics: Acute Disease; Anemia, Sickle Cell; Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Fibrinogen; Humans; Platelet Count | 1980 |
Acetylsalicylic acid in combination with dihydroergotamine for preventing thromboembolism.
Topics: Adult; Aged; Aspirin; Dihydroergotamine; Drug Therapy, Combination; Female; Fibrinogen; Humans; Male; Middle Aged; Pulmonary Embolism; Thromboembolism | 1982 |
The effect of aspirin on haemostatic activity in the treatment of chronic venous leg ulceration.
Topics: Aspirin; Double-Blind Method; Factor VIII; Female; Fibrinogen; Hemostasis; Humans; Male; Plasminogen Activator Inhibitor 1; Thrombin; Time Factors; Varicose Ulcer; von Willebrand Factor | 1995 |
Short-term aspirin treatment does not reduce plasma fibrinogen concentration in young healthy adults.
Topics: Adult; Aspirin; Fibrinogen; Humans; Male; Nephelometry and Turbidimetry; Prothrombin Time; Single-Blind Method | 1994 |
Comparison of symptomatic and asymptomatic reinfarctions after small subcortical stroke.
Topics: Aged; Aspirin; Cerebral Angiography; Cerebral Infarction; Cholesterol, HDL; Female; Fibrinogen; Follow-Up Studies; Hematocrit; Humans; Intracranial Arteriosclerosis; Lipoprotein(a); Male; Middle Aged; Neurologic Examination; Recurrence; Risk Factors; Ticlopidine; Tomography, X-Ray Computed | 1994 |
Shear-induced platelet aggregation in cerebral ischemia.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; beta-Thromboglobulin; Brain Ischemia; Cerebral Infarction; Female; Fibrinogen; Hematologic Tests; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation; Platelet Count; Ticlopidine; Time Factors; von Willebrand Factor | 1994 |
Aspirin improves the enhanced erythrocyte aggregability in patients with cerebral infarction.
Topics: Adult; Aged; Aspirin; Cerebral Infarction; Erythrocyte Aggregation; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Serum Albumin; Serum Globulins; Time Factors | 1996 |
Hemostaseologic and hematologic parameters with aspirin and ticlopidine treatment in patients with cerebrovascular disease: a cross-over study.
Topics: Adenosine Diphosphate; Aged; Aspirin; Cerebrovascular Disorders; Collagen; Cross-Over Studies; Epinephrine; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Prospective Studies; Ticlopidine | 1996 |
Continued thromboxane A2 formation despite administration of a platelet glycoprotein IIb/IIIa antagonist in patients undergoing coronary angioplasty.
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Biphenyl Compounds; Bleeding Time; Cell Division; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinogen; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Muscle, Smooth, Vascular; P-Selectin; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Thrombosis; Thromboxane A2; Thromboxane B2; Vasoconstriction | 1997 |
Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Disease; Drug Therapy, Combination; Fibrinogen; Humans; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Ticlopidine; Time Factors | 1998 |
A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Biomarkers; Cholesterol, HDL; Double-Blind Method; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Physicians; Prospective Studies; Reference Values; Risk Factors | 1999 |
Endotoxin-induced activation of the coagulation cascade in humans: effect of acetylsalicylic acid and acetaminophen.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Antigens; Antithrombin III; Aspirin; Blood Coagulation; Dimerization; Double-Blind Method; Factor VII; Factor VIIa; Fibrin; Fibrinogen; Fibrinolytic Agents; Humans; Leukocyte Count; Lipopolysaccharides; Monocytes; Neutrophils; NF-kappa B; Peptide Fragments; Platelet Count; Protein C; Protein Precursors; Prothrombin; Solubility; Thromboplastin | 1999 |
Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Dose-Response Relationship, Drug; Drug Combinations; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Platelet Aggregation Inhibitors; Prospective Studies; Reference Values; Thrombosis; von Willebrand Factor; Warfarin | 2000 |
Acute antithrombotic effect of a front-loaded regimen of clopidogrel in patients with atherosclerosis on aspirin.
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Double-Blind Method; Drug Therapy, Combination; Fibrinogen; Fibrinolytic Agents; Humans; Perfusion; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors | 2000 |
Time and dose dependent augmentation of inhibitory effects of abciximab by aspirin.
Topics: Abciximab; Acetylation; Antibodies, Monoclonal; Aspirin; Carbon Radioisotopes; Dose-Response Relationship, Drug; Drug Synergism; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Iodine Radioisotopes; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Time Factors | 2001 |
The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatment.
Topics: Adult; Aged; Anticoagulants; Aspirin; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Factor VII; Female; Fibrinogen; Graft Occlusion, Vascular; Humans; International Normalized Ratio; Male; Middle Aged; Peptide Fragments; Postoperative Complications; Postoperative Hemorrhage; Prothrombin; Recurrence; Saphenous Vein; Thrombosis; Tissue Plasminogen Activator; Treatment Outcome; von Willebrand Factor; Warfarin | 2001 |
Ciprofibrate increases plasma concentration of platelet-derived growth factor AB in patients with advanced atherosclerosis and hyperlipidemia independently of its hypolipidemic effects.
Topics: Aged; Arteriosclerosis; Aspirin; Clofibric Acid; Drug Therapy, Combination; Female; Fibric Acids; Fibrinogen; Fibrinolytic Agents; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Platelet-Derived Growth Factor | 2001 |
Measurement of platelet fibrinogen binding and p-selectin expression by flow cytometry in patients with cerebral infarction.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Platelets; Cerebral Infarction; Drug Therapy, Combination; Female; Fibrinogen; Flow Cytometry; Humans; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Protein Binding; Ticlopidine | 2001 |
Urinary 11-dehydro-thromboxane B(2) and coagulation activation markers measured within 24 h of human acute ischemic stroke.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aspirin; Biomarkers; Blood Coagulation; Brain Ischemia; Fibrinogen; Humans; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Stroke; Thromboxane B2 | 2001 |
Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury.
Topics: Adult; Alleles; Antigens, CD; Aspirin; Blood Coagulation; Blood Coagulation Tests; Coronary Thrombosis; Factor V; Factor XIII; Fibrinogen; Fibrinolytic Agents; Genetic Testing; Genotype; Heterozygote; Homozygote; Humans; Integrin beta3; Male; Microcirculation; Phospholipases A; Platelet Membrane Glycoproteins; Polymorphism, Genetic; Prothrombin; Skin; Thrombin | 2001 |
Thrombolytic therapy reduces red blood cell aggregation in plasma without affecting intrinsic aggregability.
Topics: Aged; Aspirin; Dextrans; Erythrocyte Aggregation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Plasma; Streptokinase; Thrombolytic Therapy; Tissue Plasminogen Activator | 2002 |
Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel
Topics: Aged; Aspirin; Clopidogrel; Drug Synergism; Drug Therapy, Combination; Enoxaparin; Eptifibatide; Female; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Treatment Outcome | 2004 |
Randomized clinical trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin alone after lower limb angioplasty.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Endarterectomy; Female; Fibrinogen; Flow Cytometry; Humans; Intermittent Claudication; Leg; Male; Middle Aged; P-Selectin; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome | 2005 |
Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood Viscosity; Cardiovascular Diseases; Cell Aggregation; Drug Antagonism; Drug Resistance; Drug Therapy, Combination; Erythrocytes; Female; Fibrinogen; Hematocrit; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Factors | 2006 |
Normalization of platelet reactivity in clopidogrel-treated subjects.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acid; Aspirin; Blood Platelets; Clopidogrel; Collagen; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fibrinogen; Humans; Male; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Transfusion; Platelet-Rich Plasma; Postoperative Hemorrhage; Receptors, Thrombin; Recovery of Function; Reference Values; Ticlopidine; Time Factors | 2007 |
Heparin anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery.
Topics: Aspirin; Blood Coagulation; Blood Platelets; Blood Transfusion; Coronary Artery Bypass; Coronary Artery Bypass, Off-Pump; Fibrinogen; Fibrinolytic Agents; Heparin; Heparin Antagonists; Humans; Platelet Count; Postoperative Hemorrhage; Prospective Studies; Protamines; Statistics, Nonparametric; Time Factors | 2007 |
Platelet function measured by VerifyNow identifies generalized high platelet reactivity in aspirin treated patients.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Arachidonic Acid; Aspirin; Collagen; Coronary Artery Disease; Cross-Over Studies; Double-Blind Method; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Function Tests; von Willebrand Factor | 2007 |
The effects of aspirin and nonselective beta blockade on the acute prothrombotic response to psychosocial stress in apparently healthy subjects.
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Aspirin; Coronary Thrombosis; Double-Blind Method; Drug Therapy, Combination; Factor VII; Factor XII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Propranolol; Stress, Psychological; von Willebrand Factor | 2008 |
[Removing phlegm and dispelling stasis method combined with Western medicine for treatment of cerebrovascular stenosis].
Topics: Adult; Aged; Aspirin; C-Reactive Protein; Carotid Stenosis; Cerebrovascular Disorders; Clopidogrel; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Fibrinogen; Humans; Male; Middle Aged; Phytotherapy; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome | 2008 |
Sulfotanshinone Sodium Injection could decrease fibrinogen level and improve clinical outcomes in patients with unstable angina pectoris.
Topics: Abietanes; Angina, Unstable; Anticoagulants; Aspirin; Dimerization; Drugs, Chinese Herbal; Female; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Phenanthrenes; Salvia miltiorrhiza | 2009 |
Inhibition of platelet aggregation by combined therapy with aspirin and cilostazol after off-pump coronary artery bypass surgery.
Topics: Aged; Aspirin; Cilostazol; Coronary Artery Bypass, Off-Pump; Drug Therapy, Combination; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Tetrazoles; Thrombosis; Time Factors; Treatment Outcome; von Willebrand Factor | 2008 |
Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study.
Topics: Aged; Aspirin; Case-Control Studies; Clopidogrel; Coronary Disease; Cross-Over Studies; Female; Fibrinogen; Flow Cytometry; Health; Humans; Male; Middle Aged; P-Selectin; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Principal Component Analysis; Regression Analysis; Thromboxane B2; Ticlopidine | 2009 |
Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia.
Topics: Aspirin; Atherosclerosis; Biomarkers; Blood Viscosity; C-Reactive Protein; Cognition Disorders; Executive Function; Female; Fibrinogen; Follow-Up Studies; Hematocrit; Humans; Inflammation; Inflammation Mediators; Male; Middle Aged; Neuropsychological Tests; Plasma; Risk Factors; Severity of Illness Index | 2009 |
Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
Topics: Adenosine Diphosphate; Aged; Aspirin; Atorvastatin; Clopidogrel; Comorbidity; Coronary Artery Bypass; Coronary Disease; Drug Therapy, Combination; Female; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipoproteins, LDL; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Prospective Studies; Pyrroles; Ticlopidine | 2010 |
A comparison of anticoagulation with bivalirudin and provisional GPIIb/IIIa inhibition with unfractionated heparin and mandatory GPIIb/IIIa inhibition during percutaneous coronary intervention in relation to platelet activation and the inhibition of coagu
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Biomarkers; Blood Coagulation; CD40 Ligand; Clopidogrel; Drug Therapy, Combination; Female; Fibrinogen; Heparin; Hirudins; Humans; Lipoproteins; Male; Membrane Glycoproteins; Middle Aged; Monocytes; Peptide Fragments; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prothrombin; Recombinant Proteins; Thromboplastin; Thrombosis; Ticlopidine; Treatment Outcome | 2009 |
[Changes of plasma fibrinogen level among acute ischemic stroke subtypes according to TOAST criteria and effects of Songling Xuemaikang].
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Drugs, Chinese Herbal; Female; Fibrinogen; Humans; Male; Middle Aged; Stroke; Treatment Outcome | 2010 |
Batroxobin plus aspirin reduces restenosis after angioplasty for arterial occlusive disease in diabetic patients with lower-limb ischemia.
Topics: Aged; Analysis of Variance; Angioplasty; Arterial Occlusive Diseases; Aspirin; Batroxobin; China; Constriction, Pathologic; Diabetic Angiopathies; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinogen; Fibrinolytic Agents; Humans; Ischemia; Kaplan-Meier Estimate; Limb Salvage; Lower Extremity; Magnetic Resonance Angiography; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Duplex | 2011 |
Effects of oral prednisone administration with or without ultralow-dose acetylsalicylic acid on coagulation parameters in healthy dogs.
Topics: Administration, Oral; Animals; Antithrombins; Aspirin; Blood Coagulation; Dogs; Female; Fibrinogen; Glucocorticoids; Male; Platelet Aggregation Inhibitors; Prednisone; Thrombelastography | 2012 |
Hydroxychloroquine's Efficacy as an Antiplatelet Agent Study in Healthy Volunteers: A Proof of Concept Study.
Topics: Aspirin; Cardiovascular Diseases; Fibrinogen; Healthy Volunteers; Humans; Hydroxychloroquine; Platelet Aggregation; Platelet Aggregation Inhibitors | 2015 |
The use of a biologic topical haemostatic agent (TachoSil(®)) for the prevention of postoperative bleeding in patients on antithrombotic therapy undergoing thyroid surgery: A randomised controlled pilot trial.
Topics: Administration, Topical; Aged; Aspirin; Biological Products; Drug Combinations; Female; Fibrinogen; Fibrinolytic Agents; Hemostatics; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Pilot Projects; Postoperative Hemorrhage; Prospective Studies; Thrombin; Thyroid Gland; Thyroidectomy; Vitamin K | 2015 |
Baseline Platelet Activation and Reactivity in Patients with Critical Limb Ischemia.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Case-Control Studies; Collagen; Female; Fibrinogen; Humans; Ischemia; Male; Middle Aged; Peripheral Arterial Disease; Platelet Activation; Risk Factors; Thrombin | 2015 |
220 other study(ies) available for aspirin and fibrinogen
| Article | Year |
|---|---|
Immunologic measurement of antithrombin III-heparin cofactor and alpha2 macroglobulin in disseminated intravascular coagulation and hepatic failure coagulopathy.
Topics: Alpha-Globulins; Antithrombin III; Antithrombins; Aspirin; Blood Platelets; Chemical and Drug Induced Liver Injury; Disseminated Intravascular Coagulation; Female; Fetal Proteins; Fibrinogen; Humans; Immunoelectrophoresis; Liver Cirrhosis; Macroglobulins; Male | 1975 |
Factors responsible for ADP-induced release reaction of human platelets.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Aspirin; Citrates; Fibrinogen; gamma-Globulins; Hemophilia A; Heparin; Hirudins; Humans; Magnesium; Phenylbutazone; Phosphates; Platelet Adhesiveness; Platelet Aggregation; Serum Albumin; Sulfinpyrazone; Thrombin | 1975 |
A new abnormality of platelet functions. Association of storage pool disease (thrombocytopathia A) with impaired reactivity of platelets to collagen.
Topics: Adenosine Diphosphate; Aged; Aspirin; Blood Platelet Disorders; Blood Platelets; Collagen; Fibrinogen; Glucuronidase; Humans; Male; Platelet Aggregation; Serotonin | 1975 |
Platelet retention in glass bead columns: its mechanism and the effect of plasma proteins.
Topics: Adenosine; Adenosine Monophosphate; Animals; Aspirin; Cattle; Female; Fibrinogen; gamma-Globulins; Heparin; Humans; In Vitro Techniques; Male; Platelet Adhesiveness; Serum Albumin | 1976 |
Gel-filtered human platelets. Ultrastructure, function, and role of proteins in inhibition of aggregation by aspirin.
Topics: Acetylation; Aspirin; Blood Platelets; Blood Proteins; Cell Fractionation; Chromatography, Gel; Fibrinogen; gamma-Globulins; Gelatin; Humans; In Vitro Techniques; Platelet Aggregation; Serum Albumin | 1976 |
Fibrinogen catabolism in the surgically treated patient and in those with postoperative venous thrombosis. Correlation of plasma fibrinogen chromatographic findings with 125I-labeled fibrinogen scan findings.
Topics: Adolescent; Adult; Aged; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombins; Aspirin; Chromatography, Agarose; Chromatography, Gel; Fibrinogen; Humans; Iodine Radioisotopes; Middle Aged; Neoplasms; Plasminogen; Postoperative Complications; Radionuclide Imaging; Thrombophlebitis | 1977 |
Experimental arterial thromboembolism in baboons. Mechanism, quantitation, and pharmacologic prevention.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Blood Transfusion; Dipyridamole; Disease Models, Animal; Femoral Artery; Femoral Vein; Fibrinogen; Haplorhini; Heparin; Kidney; Male; Papio; Platelet Adhesiveness; Polyurethanes; Regional Blood Flow; Silicone Elastomers; Sulfinpyrazone; Thromboembolism | 1979 |
Plasmin inhibition of thrombin-induced platelet aggregation.
Topics: Adenine Nucleotides; Aspirin; Blood Platelets; Calcium; Chelating Agents; Cold Temperature; Fibrinogen; Fibrinolysin; Humans; Hydrolysis; L-Lactate Dehydrogenase; Lysine; Platelet Adhesiveness; Platelet Aggregation; Serotonin; Thrombin; Time Factors; Trypsin Inhibitors | 1975 |
[Change in fibrinogen and enzymatic and nonenzymatic fibrinolytic activity of blood in patients with low-degree rheumatic heart disease under the effect of treatment with acetylsalicylic acid].
Topics: Adult; Aspirin; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Male; Middle Aged; Rheumatic Heart Disease; Thrombin | 1976 |
[Kinetics of I-131 fibrinogen in cancer patients: pharmacological approach].
Topics: Aspirin; Blood Coagulation; Fibrinogen; Fibrinolytic Agents; Heparin; Indomethacin; Iodine Radioisotopes; Kinetics; Neoplasms; Platelet Aggregation; Prednisone; Pyridines; Thiophenes | 1977 |
Potentiation of platelet aggregation by heat-precipitated plasma proteins.
Topics: Adenosine Diphosphate; Aspirin; Blood Proteins; Chemical Precipitation; Collagen; Epinephrine; Fibrinogen; Hemophilia A; Hot Temperature; Humans; Immunoglobulin G; In Vitro Techniques; Platelet Aggregation; von Willebrand Diseases | 1978 |
Prevention by aspirin of the classic generalized Shwartzman reaction.
Topics: Animals; Aspirin; Blood Coagulation; Disseminated Intravascular Coagulation; Endotoxins; Escherichia coli; Factor XII; Fibrinogen; Hematocrit; Kidney; Male; Platelet Aggregation; Rabbits; Shwartzman Phenomenon | 1978 |
Reduced fibrinogen survival in diabetes mellitus. A reversible phenomenon.
Topics: Adult; Aged; Aspirin; Chromatography, DEAE-Cellulose; Chromatography, Gel; Diabetes Mellitus; Dipyridamole; Electrophoresis, Polyacrylamide Gel; Female; Fibrinogen; Heparin; Humans; Hyperglycemia; Male; Middle Aged; Time Factors | 1979 |
The influence of drugs on disseminated intravascular coagulation (dic). III. Effects of busulfan-induced thrombocytopenia and inhibition of platelet function by acetylsalicylic acid.
Topics: Animals; Aspirin; Busulfan; Disseminated Intravascular Coagulation; Fibrinogen; Male; Platelet Aggregation; Rats; Thrombin; Thrombocytopenia | 1979 |
The effect of ALG on coagulation and fibrinolysis.
Topics: Animals; Antilymphocyte Serum; Aspirin; Blood Cell Count; Blood Coagulation; Blood Platelets; Dogs; Factor V; Fibrinogen; Fibrinolysis; Pulmonary Artery; Thrombocytopenia | 1978 |
Platelet and fibrin(ogen) deposition in the artificial kidney. The influence of haematocrit, fibrin monomer and platelet inhibitors. An in vitro study.
Topics: Aspirin; Blood Platelets; Chromium Radioisotopes; Fibrin; Fibrinogen; Hematocrit; Heparin; Humans; Iodine Radioisotopes; Kidneys, Artificial; Prostaglandins E | 1978 |
[Influence of acute exertion and physical training on platelet function of the coronary patient].
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Coronary Disease; Fibrinogen; Humans; Lipids; Male; Middle Aged; Myocardial Infarction; Physical Exertion; Platelet Adhesiveness; Platelet Aggregation | 1976 |
Platelet and fibrinogen survival in coronary atherosclerosis. Response to medical and surgical therapy.
Topics: Adult; Aged; Aspirin; Blood Platelets; Cell Survival; Coronary Disease; Dipyridamole; Fibrinogen; Humans; Male; Middle Aged; Myocardial Revascularization | 1977 |
The present status of acute deep venous thrombosis.
Topics: Acute Disease; Aspirin; Dextrans; Fibrinogen; Heparin; Humans; Iodine Radioisotopes; Plethysmography; Postoperative Complications; Pressure; Thrombophlebitis; Ultrasonography; Veins | 1977 |
Hemostatic alterations accompanying sickle cell pain crises.
Topics: Acute Disease; Adult; Anemia, Sickle Cell; Aspirin; Blood Cell Count; Blood Platelets; Blood Transfusion; Cyanates; Dipyridamole; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Male; Middle Aged; Pain | 1976 |
Thromboembolic disease in patients undergoing total knee replacement.
Topics: Aged; Aspirin; Fibrinogen; Humans; Joint Prosthesis; Knee Joint; Middle Aged; Phlebography; Postoperative Complications; Prospective Studies; Radionuclide Imaging; Thromboembolism; Thrombophlebitis | 1976 |
The treatment of rejection. A trial of acetylsalicylic acid, dipyridamole, and heparin.
Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Dipyridamole; Dogs; Fibrinogen; Graft Rejection; Heparin; Kidney; Kidney Transplantation; Transplantation, Autologous; Transplantation, Homologous | 1975 |
Preliminary report: treatment of the hemolytic-uremic syndrome with aspirin and dipyridamole.
Topics: Acute Disease; Anemia, Hemolytic; Aspirin; Blood Platelet Disorders; Blood Platelets; Blood Transfusion; Child; Child, Preschool; Dipyridamole; Diuresis; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythrocyte Aggregation; Female; Fibrinogen; Hemolytic-Uremic Syndrome; Heparin; Humans; Infant; Kidney Diseases; Male; Platelet Adhesiveness; Remission, Spontaneous; Thrombocytopenia | 1975 |
Platelet adhesiveness.
Topics: Anti-Inflammatory Agents; Aspirin; Blood Platelets; Collagen; Dextrans; Endothelium; Fibrinogen; Heparin; Humans; Phenylbutazone; Platelet Adhesiveness; Sialic Acids; Sulfinpyrazone; Thromboembolism | 1975 |
[A case of consumption coagulopathy due to atrial giant thrombus. Detection of thrombus by scintillation camera using fibrinogen labelled with 125I, 131I and warfarin-aspirin combination therapy (author's transl)].
Topics: Aspirin; Coronary Disease; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Female; Fibrinogen; Heart Atria; Humans; Iodine Radioisotopes; Middle Aged; Radionuclide Imaging; Thrombosis; Warfarin | 1975 |
Delivery of passivating proteins to sutures during passage through the vessel wall reduces subsequent platelet deposition by blocking fibrinogen adsorption.
Topics: Adsorption; Albumins; Arteries; Aspirin; Blood Platelets; Blotting, Western; Fibrinogen; Hemoglobins; Humans; Microscopy, Electron, Scanning; Placenta; Suture Techniques; Sutures; Thrombosis; Vascular Surgical Procedures | 1992 |
The effects of an infusion of prostacyclin on their endotoxin shock in rabbits.
Topics: Animals; Aspirin; Blood Coagulation; Blood Platelets; Blood Pressure; Carbon Dioxide; Epoprostenol; Fibrin; Fibrinogen; Lactates; Lactic Acid; Leukocyte Count; Oxygen; Partial Thromboplastin Time; Platelet Aggregation; Platelet Count; Prothrombin Time; Rabbits; Shock, Septic; Survival Analysis; Thromboxane B2 | 1990 |
Platelet activation by a synthetic hydrophobic polymer, polymethylmethacrylate.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Apyrase; Aspirin; Blood Platelets; Calcium; Chymotrypsin; Fibrinogen; Humans; Methylmethacrylates; Microscopy, Electron; Microscopy, Electron, Scanning; Microspheres; Molecular Sequence Data; Phosphorylation; Platelet Activation; Platelet Aggregation; Protein Kinase C; Serotonin | 1991 |
Inositol phospholipid metabolism in human platelets stimulated by ADP.
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Calcium; Fibrinogen; Humans; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Phosphatidic Acids; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol Phosphates; Phosphatidylinositols; Platelet Aggregation; Thromboxane A2; Type C Phospholipases | 1990 |
Tissue plasminogen activator promotes platelet disaggregation in plasma.
Topics: Adenosine Diphosphate; alpha-2-Antiplasmin; Aspirin; Blood Platelets; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Kinetics; Platelet Aggregation; Platelet Membrane Glycoproteins; Tissue Plasminogen Activator | 1987 |
Exposure of platelet fibrinogen receptors by a monoclonal antibody to CD9 antigen.
Topics: Animals; Antibodies, Monoclonal; Antigen-Antibody Reactions; Antigens, CD; Antigens, Differentiation; Aspirin; Binding Sites, Antibody; Blood Platelets; Epitopes; Fibrinogen; Humans; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Phosphocreatine; Platelet Aggregation; Platelet Membrane Glycoproteins; Tetraspanin 29; Thromboxane B2 | 1988 |
Evaluation of post-cardiopulmonary bypass Sonoclot signatures in patients taking nonsteroidal anti-inflammatory drugs.
Topics: Aspirin; Blood Loss, Surgical; Blood Platelets; Blood Viscosity; Cardiopulmonary Bypass; Evaluation Studies as Topic; Fibrinogen; Humans; Ibuprofen; Indomethacin; Partial Thromboplastin Time; Platelet Count; Protamines; Prothrombin Time; Whole Blood Coagulation Time | 1989 |
Inhibition of fibrinogen binding to human platelets by blockage of Na+/H+ exchange.
Topics: Adenosine Diphosphate; Amiloride; Aspirin; Blood Platelets; Carrier Proteins; Fibrinogen; Humans; In Vitro Techniques; Kinetics; Platelet Membrane Glycoproteins; Sodium-Hydrogen Exchangers | 1989 |
Mechanism of potentiation by manganese ion of aggregation of porcine pancreatic elastase-treated human platelets.
Topics: Aspirin; Blood Platelets; Fibrinogen; Humans; Manganese; Pancreatic Elastase; Phosphocreatine; Platelet Aggregation; Platelet Membrane Glycoproteins; Protein Conformation | 1989 |
Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels.
Topics: Acetylation; Aspirin; Blood Coagulation; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Kinetics; Male; Plasminogen Activators; Reference Values | 1989 |
Thrombogenicity of canine free internal mammary artery autografts.
Topics: Animals; Aspirin; Blood Platelets; Coronary Artery Bypass; Dipyridamole; Dogs; Fibrinogen; Kinetics; Mammary Arteries; Thoracic Arteries; Thrombosis; Tissue Distribution; Vascular Patency | 1989 |
Investigation of alternative mechanisms of collagen-induced platelet activation by using monoclonal antibodies to glycoprotein IIb-IIIa and fibrinogen.
Topics: Antibodies, Monoclonal; Aspirin; Blood Platelets; Collagen; Dose-Response Relationship, Drug; Fibrinogen; Glycoproteins; Humans; Iodine Radioisotopes; Membrane Proteins; Platelet Aggregation; Platelet Membrane Glycoproteins; Protein Binding; Structure-Activity Relationship; Thromboxane B2 | 1986 |
Activation of phospholipases A and C in human platelets exposed to epinephrine: role of glycoproteins IIb/IIIa and dual role of epinephrine.
Topics: Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Carrier Proteins; Enzyme Activation; Epinephrine; Fibrinogen; Humans; Hydrogen-Ion Concentration; Phospholipases; Phospholipases A; Platelet Membrane Glycoproteins; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Sodium-Hydrogen Exchangers; Thromboxane A2; Type C Phospholipases | 1986 |
Sex-related differences in platelet aggregation in native whole blood.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acid; Arachidonic Acids; Aspirin; Collagen; Female; Fibrinogen; Humans; Male; Platelet Aggregation; Sex Factors; Thrombin | 1987 |
Preventive effects of batroxobin on experimental canine coronary thrombosis.
Topics: Animals; Aspirin; Batroxobin; Coronary Disease; Coronary Thrombosis; Disease Models, Animal; Dogs; Electrocardiography; Fibrinogen; Hemodynamics; Heparin; Recurrence; Serine Endopeptidases; Urokinase-Type Plasminogen Activator | 1988 |
[Pharmacological and therapeutic features of cerebral ischemic conditions].
Topics: Aspirin; Blood Flow Velocity; Blood Viscosity; Brain Ischemia; Cerebrovascular Circulation; Combined Modality Therapy; Fibrinogen; Hematocrit; Hemodilution; Humans; Pentoxifylline; Platelet Aggregation; Platelet Aggregation Inhibitors | 1988 |
Endothelial cell seeding of expanded polytetrafluoroethylene vena cava conduits: effects on luminal production of prostacyclin, platelet adherence, and fibrinogen accumulation.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Dogs; Endothelium, Vascular; Epoprostenol; Female; Fibrinogen; Platelet Adhesiveness; Polytetrafluoroethylene; Vena Cava, Inferior; Warfarin | 1988 |
Platelet interaction with a pancreatic ascites tumor.
Topics: Animals; Antithrombin III; Apyrase; Ascites; Aspirin; Blood Coagulation; Blood Platelets; Cricetinae; Epoprostenol; Fibrinogen; Humans; Mesocricetus; Microscopy, Electron; Pancreatic Neoplasms; Platelet Aggregation; Platelet Count; Serotonin; Thromboxane B2 | 1986 |
The thrombopenic effect of ellagic acid in the rat. Another model of platelet stimulation "in vivo".
Topics: Animals; Aspirin; Benzopyrans; Blood Platelets; Disease Models, Animal; Ellagic Acid; Female; Fibrinogen; Male; Partial Thromboplastin Time; Pyridazines; Rats; Rats, Inbred Strains; Thrombocytopenia | 1987 |
111In-platelet and 125I-fibrinogen deposition in the lungs in experimental acute pancreatitis.
Topics: Acute Disease; Animals; Aspirin; Blood Platelets; Cell Movement; Fibrinogen; Heparin; Indium Radioisotopes; Iodine Radioisotopes; Lung; Male; Organ Size; Pancreatitis; Rats | 1987 |
Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis.
Topics: alpha-2-Antiplasmin; Aspirin; Dihydroergotamine; Drug Therapy, Combination; Fibrinogen; Glycoproteins; Heparin; Hip Prosthesis; Humans; Plasminogen Activators; Plasminogen Inactivators; Postoperative Complications; Thrombophlebitis; Tissue Plasminogen Activator | 1985 |
Fibrinogen binding to human blood platelets: effect of gamma chain carboxyterminal structure and length.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Aspirin; Blood Platelets; Fibrinogen; Humans; Macromolecular Substances; Platelet Aggregation; Protein Binding; Structure-Activity Relationship; Time Factors | 1986 |
Platelet fibrinogen binding in diabetes mellitus. Differences between binding to platelets from nonretinopathic and retinopathic diabetic patients.
Topics: Adolescent; Adult; Apyrase; Aspirin; Blood Platelets; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Female; Fibrinogen; Humans; Male; Platelet Aggregation | 1986 |
Protein/platelet interaction with an artificial surface: effect of vitamins and platelet inhibitors.
Topics: Adsorption; Amino Sugars; Animals; Aspirin; Blood Platelets; Blood Proteins; Cattle; Dipyridamole; Fibrinogen; In Vitro Techniques; Kinetics; Platelet Adhesiveness; Polycarboxylate Cement; Thrombosis; Vitamins | 1986 |
Effects of aspirin and propranolol alone and in combination on hemostatic determinants in the healthy cat.
Topics: Animals; Aspirin; Cats; Drug Combinations; Female; Fibrinogen; Hemostasis; Male; Partial Thromboplastin Time; Platelet Aggregation; Platelet Count; Propranolol; Prothrombin Time; Thrombin Time | 1985 |
The effects on lipids, blood viscosity and platelet aggregation of combined use of niceritrol (Perycit) and a low dose of acetylsalicylic acid.
Topics: Adult; Aged; Arteriosclerosis; Aspirin; Blood Viscosity; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Lipids; Male; Middle Aged; Niceritrol; Nicotinic Acids; Platelet Aggregation | 1985 |
High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trial.
Topics: Adult; Aged; Aspirin; Coronary Angiography; Dipyridamole; Drug Evaluation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Infarction; Perfusion; Plasminogen; Streptokinase | 1985 |
Rate of fibrinogen turnover in thrombosis.
Topics: Age Factors; Analysis of Variance; Aspirin; Fibrin; Fibrinogen; Humans; Iodine Radioisotopes; Methods; Placebos; Postoperative Complications; Thrombosis; Time Factors | 1972 |
Modification of platelet adherence to protein-coated surfaces.
Topics: Animals; Antimycin A; Aspirin; Caffeine; Carbon Isotopes; Cyclic AMP; Fibrinogen; gamma-Globulins; Glass; Iodine Isotopes; Iodoacetates; Phenylbutazone; Platelet Adhesiveness; Prostaglandins; Pyrimidines; Serotonin; Serum Albumin, Bovine; Sulfinpyrazone; Swine | 1973 |
Enhanced platelet function in glomerular renal disease.
Topics: Adenosine Diphosphate; Adolescent; Aspirin; Beta-Globulins; Blood Cell Count; Blood Platelets; Child; Child, Preschool; Chromatography, Gel; Collagen; Female; Fibrinogen; Glomerulonephritis; Hematocrit; Humans; Immunoglobulin G; Male; Nephrotic Syndrome; Proteinuria; Serum Albumin | 1973 |
Willebrand factor and ristocetin. I. Mechanism of rustocetin-induced platelet aggregation.
Topics: Adenosine Diphosphate; Albumins; Aspirin; Carbon Radioisotopes; Chromatography, Gel; Dose-Response Relationship, Drug; Factor VIII; Fibrinogen; gamma-Globulins; Hemophilia A; Humans; Platelet Adhesiveness; Platelet Aggregation; Ristocetin; Serotonin; von Willebrand Diseases | 1974 |
Platelet-surface reaction and thrombosis.
Topics: Animals; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Carbon Isotopes; Endarterectomy; Extracorporeal Circulation; Femoral Artery; Fibrinogen; gamma-Globulins; Glass; Humans; In Vitro Techniques; Polymers; Popliteal Artery; Pulse; Rabbits; Serotonin; Serum Albumin; Sulfinpyrazone; Sulfur Isotopes; Surface Properties; Thrombosis; Transplantation, Autologous; Vascular Surgical Procedures | 1968 |
In vitro acetylation of plasma proteins, enzymes and DNA by aspirin.
Topics: Acetates; Animals; Aspirin; Blood Proteins; Carbon Isotopes; Chemical Phenomena; Chemistry; Deoxyribonucleases; Dialysis; DNA; Enzymes; Fibrinogen; gamma-Globulins; Growth Hormone; Histones; Hyaluronic Acid; Hyaluronoglucosaminidase; In Vitro Techniques; Macroglobulins; Muramidase; Neoplasm Proteins; Pepsin A; Prolactin; Ribonucleases; Serum Albumin; Thyroglobulin; Transferrin; Urea | 1968 |
[The inhibition of thrombocyte aggregation in vitro and in vivo].
Topics: Anti-Inflammatory Agents; Arachidonic Acids; Aspirin; Blood Platelets; Dipyridamole; Fatty Acids, Essential; Fibrinogen; Fluorides; Gentisates; Humans; In Vitro Techniques; Iodoacetates; Nicotinic Acids; Papaverine; Phenylbutazone; Platelet Adhesiveness; Prostaglandins; Sodium; Thrombosis; Vasodilator Agents | 1969 |
Thrombocytopathia with abnormalities in platelet release reaction. Some evidence for platelet factor 4 deficiency.
Topics: Acid Phosphatase; Adenosine Diphosphate; Aged; Aspirin; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelet Disorders; Collagen; Epinephrine; Fibrinogen; Glucuronidase; Heparin; Humans; Male; Platelet Adhesiveness; Thrombin | 1973 |
Prevention of vessel wall damage in experimental irradiation.
Topics: Animals; Antifibrinolytic Agents; Aspirin; Blood Coagulation; Blood Vessels; Carotid Arteries; Cyclohexanecarboxylic Acids; Fibrin; Fibrinogen; Glycosaminoglycans; Heparin; Lipid Metabolism; Methylamines; Platelet Adhesiveness; Prednisone; Rabbits; Radiation Injuries, Experimental | 1973 |
Human platelet clumping by bovine fibrinogen.
Topics: Adenosine; Adenosine Diphosphate; Afibrinogenemia; Animals; Aspirin; Blood Platelets; Cattle; Chromatography, Gel; Depression, Chemical; Edetic Acid; Fibrinogen; Fibrinolysin; Hot Temperature; Humans; Male; Plasma; Platelet Adhesiveness | 1972 |
Comparative effects of proteinase inhibitors, plasminogen antiactivators, heparin and acetylsalicylic acid on the experimental disseminated intravascular coagulation induced by thormbin.
Topics: Aminocaproates; Animals; Aprotinin; Aspirin; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Cyclohexanecarboxylic Acids; Disseminated Intravascular Coagulation; Enzyme Activation; Enzyme Inhibitors; Fibrin; Fibrinogen; Fibrinolysin; Heparin; Heparin Antagonists; Kidney; Lung; Methylamines; Plasminogen; Platelet Aggregation; Protease Inhibitors; Thrombin; Thromboplastin | 1974 |
The effects of some anti-inflammatory drugs on the acute-phase proteins in rheumatoid arthritis.
Topics: Adrenocorticotropic Hormone; Adult; Analgesics; Arthritis, Rheumatoid; Aspirin; Blood Sedimentation; C-Reactive Protein; Fibrinogen; Glucocorticoids; Haptoglobins; Humans; Indomethacin; Prednisone | 1973 |
The inhibitory effect of non-steroidal anti-inflammatory agents on aggregation of red cells in vitro.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Blood Sedimentation; Dextrans; Erythrocytes; Female; Fibrinogen; Flufenamic Acid; Gelatin; Glucocorticoids; Histamine H1 Antagonists; In Vitro Techniques; Indomethacin; Male; Mefenamic Acid; Phenylbutazone; Rats; Salicylates | 1970 |
Modification of platelet function.
Topics: Animals; Antigen-Antibody Complex; Aspirin; Blood Coagulation; Blood Platelets; Calcium; Cell Movement; Cyclic AMP; Dipyridamole; Energy Transfer; Fibrinogen; Histamine H1 Antagonists; Humans; Platelet Adhesiveness; Prostaglandins; Rabbits; Thrombosis; Xanthines | 1972 |
[The continuous measurement of platelet aggregation without the addition of aggregation inducers. II. Experimental results and testing of aggregation inducers].
Topics: Aspirin; Benzyl Compounds; Cycloheptanes; Dimethylamines; Ethanolamines; Fibrinogen; Humans; In Vitro Techniques; Morpholines; Photometry; Piperazines; Piperidines; Platelet Adhesiveness; Platelet Aggregation; Polysaccharides; Pyrimidines; Sulfuric Acids; Thiophenes | 1974 |
Alterations in platelet aggregation associated with adjuvant arthritis in rats.
Topics: Adenosine Diphosphate; Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Arthritis; Aspirin; Collagen; Disease Models, Animal; Female; Fibrinogen; Indomethacin; Mycobacterium; Phenylbutazone; Platelet Adhesiveness; Platelet Aggregation; Rats; Time Factors | 1974 |
Direct assessment of platelet adhesion to glass: a study of the forces of interaction and the effects of plasma and serum factors, platelet function, and modification of the glass surface.
Topics: Adenosine Diphosphate; Adsorption; Anticoagulants; Aspirin; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Blood Group Incompatibility; Calcium; Fibrinogen; Glass; Hemophilia A; Humans; Magnesium; Platelet Adhesiveness; Polyethylenes; Temperature; Thrombin; von Willebrand Diseases | 1972 |
The prevention of endotoxin-induced glomerular fibrin deposition by pyrimido-pyrimidine compounds.
Topics: Animals; Aspirin; Blood Cell Count; Blood Platelets; Disseminated Intravascular Coagulation; Endotoxins; Escherichia coli; Female; Fibrin; Fibrinogen; Injections, Intravenous; Kidney Glomerulus; Microcirculation; Morpholines; Pyrimidines; Rabbits; Thiophenes | 1972 |
A kinetic evaluation of hemostasis in renal disease.
Topics: Aspirin; Blood Coagulation; Complement System Proteins; Diabetic Nephropathies; Dipyridamole; Fibrin; Fibrinogen; Glomerulonephritis; Hemolytic-Uremic Syndrome; Heparin; Humans; Iodine Radioisotopes; Kidney; Kidney Diseases; Kidney Glomerulus; Kidney Transplantation; Plasminogen; Proteinuria; Thrombosis; Transplantation, Homologous; Uremia; Warfarin | 1974 |
The possible role of platelets as trigger in intravascular coagulation associated with acute hyperparathyroidism.
Topics: Adenosine Diphosphate; Animals; Aspirin; Blood Cell Count; Blood Platelets; Calcium; Carcinoma 256, Walker; Collagen; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hypercalcemia; Hyperparathyroidism; Neoplasm Transplantation; Parathyroid Hormone; Platelet Adhesiveness; Radiation Effects; Rats; Sarcoma, Yoshida; Thromboplastin; Time Factors; Transplantation, Homologous | 1972 |
Aggregation and release reaction in normal and abnormal platelets.
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation Factors; Blood Platelet Disorders; Blood Platelets; Calcium; Centrifugation; Collagen; Depression, Chemical; Dose-Response Relationship, Drug; Epinephrine; Fibrinogen; Humans; In Vitro Techniques; Kaolin; Magnesium; Platelet Adhesiveness; Stimulation, Chemical; Temperature; Thrombin | 1972 |
Chronic intravascular coagulation syndrome associated with atherosclerotic aortic aneurysm.
Topics: Aged; Aortic Aneurysm; Arteriosclerosis; Aspirin; Blood Cell Count; Blood Platelets; Chronic Disease; Coronary Disease; Dipyridamole; Disseminated Intravascular Coagulation; Female; Fibrinogen; Heparin; Humans; Time Factors | 1973 |
Aspirin in the prevention of thrombosis.
Topics: Aspirin; Fibrinogen; Humans; Iodine Radioisotopes; Platelet Adhesiveness; Postoperative Complications; Thrombosis | 1973 |
Action of coagulation factors on experimental thrombogenesis and their changes after thrombosis.
Topics: Animals; Aspirin; Benzopyrans; Blood; Blood Cell Count; Blood Coagulation Factors; Blood Platelets; Fibrinogen; Hematocrit; Jugular Veins; Ketones; Male; Rats; Thrombosis | 1973 |
Altering diffusion rates.
Topics: Aspirin; Blood Glucose; Blood Proteins; Diffusion; Ethanol; Ethyl Ethers; Fibrinogen; Humans; Oxygen; Pentobarbital; Serum Albumin; Serum Globulins; Time Factors | 1973 |
Coagulopathies in septic shock.
Topics: Animals; Aspirin; Blood Cell Count; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Disseminated Intravascular Coagulation; Dogs; Fibrinogen; Humans; Protamines; Shock, Septic; Thrombin | 1973 |
Thrombotic thrombocytopenic purpura--coagulation parameters in twelve patients.
Topics: Adolescent; Adult; Anemia, Hemolytic; Antigens; Aspirin; Blood Coagulation; Blood Coagulation Tests; Bone Marrow Examination; Dipyridamole; Disseminated Intravascular Coagulation; Female; Fibrinogen; Glucocorticoids; Hemagglutination Inhibition Tests; Heparin; Humans; Male; Middle Aged; Prothrombin Time; Purpura, Thrombotic Thrombocytopenic; Spleen; Splenectomy | 1973 |
Dipyridamole ("Persantin") and aspirin and the prevention of post-operative deep-vein thrombosis.
Topics: Adult; Aspirin; Dextrans; Dipyridamole; Drug Therapy, Combination; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Platelet Aggregation; Postoperative Complications; Thrombophlebitis | 1973 |
Aggregation and release reaction induced in human blood platelets by zymosan.
Topics: Adenine Nucleotides; Aspirin; Blood Platelets; Carbon Radioisotopes; Erythrocytes; Fibrinogen; Glucuronidase; Hemagglutination Tests; Humans; L-Lactate Dehydrogenase; Platelet Adhesiveness; Serotonin; Tannins; Zymosan | 1974 |
The effect of moderate doses of chlorpromazine on the haemostasis in dogs defibrinogenated with defibrase.
Topics: Afibrinogenemia; Animals; Aspirin; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Chlorpromazine; Dogs; Fibrinogen; Peptide Hydrolases; Snakes; Venoms | 1974 |
Effect of aspirin on microaggregate formation in banked blood.
Topics: Adult; Aspirin; Blood Banks; Blood Preservation; Fibrin; Fibrinogen; Humans; Male; Platelet Adhesiveness; Thrombin | 1974 |
Arterial and venous thromboembolism: kinetic characterization and evaluation of therapy.
Topics: Adult; Aged; Arteriosclerosis; Aspirin; Blood Cell Count; Blood Platelets; Dipyridamole; Drug Synergism; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Plasminogen; Thromboembolism; Thrombophlebitis; Warfarin | 1974 |
Platelet aggregation and release by ADP and thrombin: evidence for two separate effects of ADP on platelets, involvement of fibrinogen in release, and mechanism of inhibitory action of acetylsalicylic acid.
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation Factors; Blood Platelets; Fibrin; Fibrinogen; Heparin; Humans; In Vitro Techniques; Models, Biological; Models, Theoretical; Platelet Adhesiveness; Prothrombin; Pyrophosphatases; Spectrophotometry; Surface Properties; Thrombin | 1974 |
Bleeding disorders during surgery.
Topics: Adrenal Cortex Hormones; Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Extracorporeal Circulation; Female; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Hemostasis; Humans; Liver Diseases; Male; Neoplasms; Purpura, Thrombocytopenic; Surgical Procedures, Operative; Thrombocytopenia; Transfusion Reaction | 1974 |
Thrombotic thrombocytopenic purpura. Three cases with platelet and fibrinogen survival studies.
Topics: Adolescent; Antibodies; Aspirin; Blood Coagulation Tests; Blood Platelets; Cell Survival; Child; Chromium Radioisotopes; Dipyridamole; Enterovirus; Female; Fibrinogen; Heparin; Humans; Iodine Radioisotopes; Kidney; Male; Purpura, Thrombotic Thrombocytopenic; Thrombin | 1974 |
Aggregation of human platelets by commercial preparations of bovine and porcine antihaemophilic globulin.
Topics: Adenosine; Animals; Aspirin; Blood Cell Count; Cattle; Densitometry; Factor VIII; Fibrinogen; Goats; Hemoglobinometry; Hemophilia A; Heparin; Horses; Humans; In Vitro Techniques; Platelet Adhesiveness; Sheep; Spectrum Analysis; Swine; Temperature; Thrombocytopenia; Trichloroacetic Acid | 1972 |
Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 2. Action on local and systemic chemical responses in the rat with an experimental inflammatory process.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Blood Proteins; Carrageenan; Collagen; Female; Fibrinogen; Hexosamines; Hydrocortisone; Hydroxyproline; Inflammation; Kaolin; Male; Neuraminic Acids; Phenylbutazone; Prednisolone; Pyrazoles; Rats; Terpenes | 1972 |
Pathogenesis of epizootic hemorrhagic disease. I. Blood coagulation during viral infection.
Topics: Animals; Aspirin; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Blood Vessels; Deer; Drug Synergism; Factor VIII; Fibrinogen; Hemorrhagic Fevers, Viral; Heparin; Prothrombin Time; Splenectomy; Venoms | 1971 |
[The lung in shock: accumulation of thrombocytes following trauma and intravasal coagulation].
Topics: Animals; Aspirin; Blood Platelets; Chromium Isotopes; Dogs; Fibrinogen; Iodine Radioisotopes; Kidney; Lung; Muscles; Platelet Adhesiveness; Protamines; Shock, Traumatic; Thrombin; Vascular Resistance; Ventilation-Perfusion Ratio | 1971 |
Action of fibrinogen degradation products and fibrin monomer soluble complexes on platelet aggregation.
Topics: Acid Phosphatase; Adenosine Diphosphate; Antigens; Aspirin; Blood Coagulation; Chromatography, Gel; Collagen; Dialysis; Epinephrine; Fibrin; Fibrinogen; Hot Temperature; Humans; Hydrogen-Ion Concentration; Molecular Weight; Phosphoenolpyruvate; Platelet Adhesiveness; Pyruvate Kinase; Solubility; Thrombin | 1971 |
Circulatory and respiratory effects of induced platelet aggregation. An experimental study in dogs.
Topics: Animals; Aspirin; Blood Cell Count; Blood Circulation; Blood Pressure; Chromium Isotopes; Disseminated Intravascular Coagulation; Dogs; Erythrocyte Aggregation; Fibrinogen; Heparin; Iodine Isotopes; Iron Isotopes; Lung Compliance; Platelet Adhesiveness; Protamines; Pulmonary Circulation; Respiration; Thrombin; Vasoconstrictor Agents; Vasodilator Agents | 1971 |
Coagulation defects in undiagnosed recurrent gastrointestinal bleeding.
Topics: Adult; Aged; Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Factor VIII; Factor XI Deficiency; Female; Fibrinogen; Fibrinolysis; Gastrointestinal Hemorrhage; Hemophilia A; Hemophilia B; Hemorrhagic Disorders; Humans; Male; Middle Aged; Platelet Adhesiveness; Prothrombin Time; von Willebrand Diseases | 1970 |
Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves.
Topics: Aortic Valve; Aspirin; Blood Cell Count; Blood Platelets; Chromium Isotopes; Dipyridamole; Drug Synergism; Fibrinogen; Heart Valve Prosthesis; Humans; Kinetics; Mitral Valve; Postoperative Complications; Spectrophotometry; Thromboembolism; Transplantation, Homologous | 1970 |
Platelet aggregation induced by soluble fibrin monomer complexes.
Topics: Acid Phosphatase; Adenine Nucleotides; Aspirin; Blood Coagulation; Blood Platelets; Fibrin; Fibrinogen; Humans; Nucleosides; Platelet Adhesiveness; Pyruvate Kinase; Pyruvates | 1970 |
Demonstration of a plasmatic cofactor different from fibrinogen necessary for platelet release by ADP and adrenaline.
Topics: Adenine Nucleotides; Aspirin; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Collagen; Epinephrine; Fibrinogen; Heparin; Heparin Antagonists; Humans; Magnesium; Platelet Adhesiveness; Thrombin | 1970 |
Purpura and acetylsalicylic acid therapy.
Topics: Adenine Nucleotides; Aspirin; Blood Platelets; Child; Epinephrine; Factor V; Female; Fibrinogen; Humans; In Vitro Techniques; Infant; Male; Phospholipids; Prothrombin; Purpura | 1971 |
Fibrinogen and platelets in the primary arrest of bleeding. Studies in two patients with congenital afibrinogenemia.
Topics: Adenine Nucleotides; Adult; Afibrinogenemia; Aspirin; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Carbon Isotopes; Cell Aggregation; Citrates; Connective Tissue; Epinephrine; Female; Fibrinogen; Hemostasis; Heparin; Humans; In Vitro Techniques; Kaolin; Male; Platelet Adhesiveness; Serotonin | 1971 |
[The effect of aspirin on the blood coagulation system of rheumatic children].
Topics: Adolescent; Aspirin; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Child; Child, Preschool; Fibrinogen; Fibrinolysis; Heparin; Humans; Rheumatic Fever; Thrombelastography | 1966 |
Postoperative venous thrombosis. Evaluation of five methods of treatment.
Topics: Adult; Age Factors; Aged; Aspirin; Clothing; Dextrans; Female; Fibrinogen; Heparin; Humans; Iodine Radioisotopes; Male; Middle Aged; Obesity; Postoperative Complications; Pulmonary Embolism; Risk; Thrombophlebitis | 1981 |
[Preoperative hemodilution as prophylaxis of deep vein thrombosis].
Topics: Adult; Aged; Aspirin; Dextrans; Fibrinogen; Hemodilution; Humans; Middle Aged; Phlebography; Preoperative Care; Thrombophlebitis | 1984 |
Effects of any epoxymethano stable analogue of prostaglandin endoperoxides (U-46619) on human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aspirin; Blood Platelets; Calcium; Cyclic AMP; Fibrinogen; Humans; L-Lactate Dehydrogenase; Magnesium; Malondialdehyde; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Serotonin; Thromboxane B2 | 1981 |
A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors.
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Epinephrine; Fibrinogen; Humans; Indomethacin; Platelet Aggregation; Platelet Membrane Glycoproteins; Prostaglandins; Prostaglandins A; Prostaglandins H; Receptors, Cell Surface; Thromboxanes | 1981 |
Platelet aggregation by Streptococcus pyogenes.
Topics: Aspirin; Blood Platelets; Edetic Acid; Escherichia coli; Fibrinogen; Humans; Platelet Aggregation; Quinacrine; Serotonin; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes | 1983 |
Activation of blood coagulation in cancer: Trousseau's syndrome revisited.
Topics: Antibodies; Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Cell Adhesion; Cell Communication; Cyclooxygenase Inhibitors; Disseminated Intravascular Coagulation; Epoprostenol; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Humans; Indomethacin; Monocytes; Neoplasm Transplantation; Neoplasms; Syndrome; Thrombocytopenia; Thrombocytosis; Thromboembolism; Thromboplastin | 1983 |
Thrombospondin plays a role in platelet-platelet recognition during release-related aggregation.
Topics: Adenosine Diphosphate; Antibodies, Monoclonal; Aspirin; Fibrinogen; Glycoproteins; Humans; Immune Sera; Platelet Aggregation; Thrombospondins | 1984 |
Platelet-platelet recognition during aggregation: distinct mechanisms determined by the release reaction.
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Dose-Response Relationship, Drug; Fibrinogen; Humans; Platelet Aggregation | 1984 |
Hematin: unique effects of hemostasis.
Topics: Adult; Aspirin; Blood Coagulation Disorders; Blood Coagulation Tests; Fibrinogen; Glucose; Heme; Hemin; Heparin; Humans; In Vitro Techniques; Male; Platelet Aggregation; Porphyrias | 1983 |
Passive participation of fixed platelets in aggregation facilitated by covalently bound fibrinogen.
Topics: Apyrase; Aspirin; Blood Platelets; Cell Communication; Cell Separation; Fibrinogen; Formaldehyde; Humans; Platelet Aggregation; Thrombin | 1983 |
Effects of ticlopidine and aspirin on endotoxin-induced disseminated intravascular coagulation in rats.
Topics: Animals; Aspirin; Disease Models, Animal; Disseminated Intravascular Coagulation; Endotoxins; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Kidney Glomerulus; Partial Thromboplastin Time; Platelet Count; Prothrombin Time; Rats; Rats, Inbred Strains; Thiophenes; Ticlopidine | 1983 |
[Selective anti-aggregation--a new concept for inhibitors of the platelet function (author's transl)].
Topics: Aspirin; Calcium; Depression, Chemical; Fibrinogen; Humans; Platelet Aggregation; Prostaglandins; Sialic Acids; Temperature; Thromboxanes | 1981 |
Practical impact of hemorheology on the treatment of chronic peripheral ischemia.
Topics: Ancrod; Aspirin; Blood Viscosity; Chronic Disease; Erythrocyte Count; Fibrinogen; Humans; Intermittent Claudication; Ischemia; Lipid Metabolism; Myocardial Infarction; Plasma Exchange; Rheology; Vascular Diseases; Vasodilator Agents | 1981 |
Direct comparison of biomaterials and endothelium in an ex vivo shunt.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Biocompatible Materials; Blood Vessels; Dogs; Endothelium; Evaluation Studies as Topic; Fibrinogen; Male; Platelet Adhesiveness; Thrombosis | 1981 |
Antithrombotic effects of ticlopidine, acetylsalicyclic acid and dipyridamole in vascular shunt model in rats.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Coagulation; Blood Coagulation Tests; Dipyridamole; Fibrinogen; Fibrinolytic Agents; Hematocrit; Male; Platelet Aggregation; Platelet Count; Pyridines; Rats; Serum Globulins; Thiophenes; Ticlopidine | 1980 |
Platelet changes after placement of aortic prostheses in dogs. II. Impaired surface-induced arterial thrombosis.
Topics: Animals; Aorta; Arterial Occlusive Diseases; Arteries; Aspirin; Blood Coagulation; Blood Platelets; Dogs; Female; Fibrinogen; Heparin; Leukocyte Count; Male; Partial Thromboplastin Time; Platelet Count; Prostheses and Implants; Prothrombin Time; Thrombosis; Time Factors | 1981 |
Effect of low dose aspirin on augmented plasminogen activator inhibitor type 1 activity in patients with permanent pacemakers.
Topics: Adult; Aged; Aged, 80 and over; Antithrombin III; Aspirin; Blood Coagulation; Blood Platelets; Female; Fibrinogen; Heart Block; Humans; Male; Middle Aged; Pacemaker, Artificial; Partial Thromboplastin Time; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Prothrombin Time; Sick Sinus Syndrome; Tissue Plasminogen Activator | 1994 |
Influence of anti-inflammatory treatments on experimental infection of rats with Fasciola hepatica: changes in serum levels of inflammatory markers during the early stages of fasciolosis.
Topics: Acute-Phase Proteins; Analysis of Variance; Animals; Antibodies, Helminth; Antibody Formation; Antigens, Helminth; Aspirin; Biomarkers; Complement C3; Cyclosporine; Dexamethasone; Fasciola hepatica; Fascioliasis; Female; Fibrinogen; Indomethacin; Inflammation; Leukocyte Count; Male; Platelet Count; Rats; Rats, Wistar; Time Factors | 1994 |
Aspirin does not affect the flow cytometric detection of fibrinogen binding to, or release of alpha-granules or lysosomes from, human platelets.
Topics: Adenosine Diphosphate; Adult; Antigens, CD; Aspirin; Blood Platelets; Cell Degranulation; Dose-Response Relationship, Drug; Drug Interactions; Fibrinogen; Flow Cytometry; Humans; Male; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Membrane Glycoproteins; Tetraspanin 30; Thrombin | 1994 |
[Evaluation, by flow cytometry, of activated platelet levels after coronarography and intraluminal angioplasty].
Topics: Adenosine Diphosphate; Adult; Aged; Angioplasty, Balloon; Aspirin; Coronary Angiography; Female; Fibrinogen; Flow Cytometry; Humans; Male; Middle Aged; Platelet Activation; Platelet Count | 1995 |
The effects of KBT-3022, a new anti-platelet agent, on hemorheological properties in guinea pigs.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Animals; Aspirin; Blood Viscosity; Diphosphoglyceric Acids; Drug Evaluation, Preclinical; Erythrocyte Deformability; Fibrinogen; Guinea Pigs; Hematocrit; Hemorheology; Pentoxifylline; Plasma; Platelet Aggregation Inhibitors; Pyrroles; Thiazoles; Ticlopidine | 1995 |
Platelet response to vascular surgery--a preliminary study on the effect of aspirin and heparin.
Topics: Adult; Aged; Aspirin; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Postoperative Complications; Vascular Diseases | 1994 |
Thrombelastographic patterns following abdominal aortic surgery.
Topics: Aged; Aged, 80 and over; Analgesia, Epidural; Anesthesia, General; Antithrombin III; Aorta, Abdominal; Aspirin; Blood Coagulation; Blood Loss, Surgical; Blood Transfusion; Factor VIII; Fibrinogen; Fluid Therapy; Humans; Middle Aged; Platelet Count; Thrombelastography; Thrombosis | 1994 |
Inhibition of growth of thrombus on fresh mural thrombus. Targeting optimal therapy.
Topics: Animals; Aspirin; Fibrinogen; Heparin; Hirudin Therapy; Partial Thromboplastin Time; Swine; Thrombin; Thrombosis | 1994 |
Effect of plasma fibrinogen concentration on the inhibition of platelet aggregation after ticlopidine compared with aspirin.
Topics: Adenosine Diphosphate; Aged; Aspirin; Cerebral Infarction; Cerebrovascular Disorders; Collagen; Female; Fibrinogen; Humans; Male; Platelet Aggregation; Platelet Count; Ticlopidine | 1994 |
Effect of single oral dose of aspirin on human platelet functions and plasma plasminogen activator inhibitor-1.
Topics: Adenosine Diphosphate; Arachidonic Acid; Aspirin; Blood Platelets; Epinephrine; Female; Fibrinogen; Humans; In Vitro Techniques; Male; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Time Factors | 1993 |
Variable and circadian response to a fixed high-dose (12 500 IU twice daily) subcutaneous heparin regimen after thrombolytic therapy for acute myocardial infarction.
Topics: Aspirin; Blood Coagulation Tests; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fibrinogen; Heparin; Humans; Injections, Subcutaneous; Male; Middle Aged; Myocardial Infarction; Streptokinase; Thrombolytic Therapy | 1994 |
Type IV Ehlers-Danlos syndrome with aspirin sensitivity. A family study.
Topics: Adult; Aspirin; Blood Coagulation; Blood Platelets; Child; Collagen; Ehlers-Danlos Syndrome; Female; Fibrinogen; Humans; Male; Pedigree; Platelet Aggregation | 1993 |
Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke.
Topics: Adult; Age Factors; Aged; Analysis of Variance; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Female; Fibrinogen; Heparin; Humans; Hypertension; Male; Middle Aged; Pilot Projects; Recombinant Proteins; Retrospective Studies; Sex Factors; Thrombolytic Therapy; Tissue Plasminogen Activator | 1994 |
Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
Topics: Animals; Anticoagulants; Arterio-Arterial Fistula; Aspirin; Carotid Artery Thrombosis; Clopidogrel; Collagen; Disease Models, Animal; Drug Evaluation, Preclinical; Fibrin; Fibrinogen; Fibrinolytic Agents; Glass; Heparin; Hirudin Therapy; Hirudins; Male; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Polyethylenes; Rats; Rats, Wistar; Recombinant Proteins; Regional Blood Flow; Silicones; Thrombin; Ticlopidine | 1993 |
Electrophoretic light scattering studies on the interaction of fibrinogen with resting and activated human platelets.
Topics: Aspirin; Blood Platelets; Electrophoresis; Epinephrine; Fibrinogen; Humans; Nephelometry and Turbidimetry; Platelet Activation; Platelet Membrane Glycoproteins; Protein Binding; Thrombin | 1993 |
Roles of phospholipase C and Ca(2+)-ATPase in calcium responses of single, fibrinogen-bound platelets.
Topics: Adenosine Diphosphate; Apyrase; Aspirin; Blood Platelets; Calcium; Calcium-Transporting ATPases; Cytosol; Egtazic Acid; Fibrinogen; Fura-2; Humans; Inositol Phosphates; Kinetics; Platelet Activation; Spectrometry, Fluorescence; Terpenes; Thapsigargin; Thrombin; Type C Phospholipases; Video Recording | 1993 |
Coagulation-fibrinolysis system in poststroke patients receiving antiplatelet medication.
Topics: Aged; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antithrombin III; Aspirin; Blood Coagulation; Cerebrovascular Disorders; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Male; Middle Aged; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Ticlopidine; Tissue Plasminogen Activator | 1993 |
Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schatz stenting.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anticoagulants; Aspirin; Blood Platelets; Coronary Disease; Coronary Thrombosis; Female; Fibrinogen; Heparin; Humans; Logistic Models; Male; Middle Aged; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Risk Factors; Stents; Treatment Outcome | 1996 |
Platelet activation and thrombosis: studies in a patient with essential thrombocythemia.
Topics: Adenosine Diphosphate; Adult; Antibodies, Monoclonal; Aspirin; Blood Platelets; Disease Susceptibility; Female; Fibrinogen; Flow Cytometry; Humans; Mesenteric Arteries; Mesenteric Vascular Occlusion; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Portal Vein; Receptors, Purinergic P2; Splenic Vein; Thrombocythemia, Essential; Thrombosis; Ticlopidine | 1996 |
Platelet activation and coronary stent implantation. Effect of antithrombotic therapy.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Case-Control Studies; Coronary Vessels; Female; Fibrinogen; Fibrinolytic Agents; Heparin; Humans; Male; Middle Aged; P-Selectin; Phenprocoumon; Platelet Activation; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Ticlopidine | 1996 |
Primary thrombocythemia and pregnancy: treatment and outcome in fifteen cases.
Topics: Adult; Aspirin; Female; Fibrinogen; Fibrinolytic Agents; Gestational Age; Hemoglobins; Heparin; Humans; Leukocyte Count; Platelet Aggregation Inhibitors; Platelet Count; Polycythemia Vera; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Protein S; Thrombocytosis; Treatment Outcome | 1996 |
Evaluation of arginine-glycine-aspartate-containing peptides as inhibitors of equine platelet function.
Topics: Animals; Arginine; Aspartic Acid; Aspirin; Blood Coagulation; Blood Platelets; Dose-Response Relationship, Drug; Fibrinogen; Glycine; Horses; Oligopeptides; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex | 1997 |
[Initial evaluation of the ACL-Futura coagulation analyzer].
Topics: Acenocoumarol; Adult; Antithrombin III; Aspirin; Bilirubin; Blood Coagulation; Blood Coagulation Tests; Child; Colorimetry; Evaluation Studies as Topic; Female; Fibrinogen; Heparin; Humans; Infant, Newborn; Lipids; Male; Nephelometry and Turbidimetry; Pregnancy; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Tissue Plasminogen Activator | 1996 |
Distribution of adhesion molecules on HeLa cells, platelets and endothelium in an in vitro model mimicking the early phase of metastasis. An immunogold electron microscopic study.
Topics: Aspirin; Blood Platelets; Cell Adhesion; Cell Adhesion Molecules; Endothelium, Vascular; Fibrinogen; HeLa Cells; Humans; Membrane Glycoproteins; Neoplasm Metastasis; P-Selectin; Platelet Endothelial Cell Adhesion Molecule-1; Thrombospondins; von Willebrand Factor | 1997 |
Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine, and procoagulant activity of adherent platelets: evidence for regulation by protein tyrosine kinase-dependent Ca2+ responses.
Topics: Androstadienes; Aspirin; Blood Coagulation; Blood Platelets; Calcimycin; Calcium; Cell Membrane; Chelating Agents; Collagen; Egtazic Acid; Enzyme Inhibitors; Estrenes; Fibrinogen; Genistein; Humans; Ion Transport; Membrane Lipids; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Microscopy, Video; P-Selectin; Phosphatidylserines; Phosphorylation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Pyrrolidinones; Signal Transduction; Thrombin; Wortmannin | 1997 |
Involvement of fibrinogen in protamine-induced pulmonary hypertension.
Topics: Animals; Aspirin; Blood; Blood Pressure; Cattle; Cyclooxygenase Inhibitors; Disease Models, Animal; Fibrinogen; Heparin; Hypertension, Pulmonary; Perfusion; Protamines; Pulmonary Artery; Rats; Rats, Sprague-Dawley | 1997 |
Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
Topics: Adenosine Diphosphate; Antibodies, Monoclonal; Apyrase; Aspirin; Blood Platelets; Calcium; Cyclooxygenase Inhibitors; Dipeptides; Fibrinogen; Humans; Ion Transport; Peptide Fragments; Phenylacetates; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Thrombin; Signal Transduction; Sulfonamides; Thrombin; Thromboxane A2; Thromboxane B2; Tirofiban; Tyrosine | 1998 |
In vivo effects of contrast media on coronary thrombolysis.
Topics: alpha-2-Antiplasmin; Animals; Antithrombin III; Aspirin; Contrast Media; Coronary Thrombosis; Diatrizoate; Dogs; Drug Interactions; Fibrinogen; Hemostasis; Iohexol; Ioxaglic Acid; Myocardial Reperfusion; Partial Thromboplastin Time; Peptide Hydrolases; Thrombolytic Therapy; Tissue Plasminogen Activator | 1998 |
Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors.
Topics: Abciximab; Animals; Antibodies, Monoclonal; Aspirin; Binding, Competitive; Biphenyl Compounds; CHO Cells; Cricetinae; Disintegrins; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Indomethacin; Mice; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Pyrrolidines; Recombinant Fusion Proteins | 1998 |
Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
Topics: Abciximab; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Binding Sites; Blood Platelets; Coronary Disease; Drug Therapy, Combination; Female; Fibrinogen; Gene Expression Regulation; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Ligands; Male; Middle Aged; Myocardial Ischemia; P-Selectin; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Stents; Thrombocytopenia; Ticlopidine | 1998 |
Differences between activation thresholds for platelet P-selectin glycoprotein IIb-IIIa expression and their clinical implications.
Topics: Aspirin; Blood Platelets; Coronary Disease; Fibrinogen; Humans; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding | 1999 |
Markers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; beta-Thromboglobulin; Biomarkers; Factor V; Female; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Multivariate Analysis; Peptide Fragments; Phlebotomy; Prothrombin; Sex Factors; Stroke; Thromboembolism; Warfarin | 1999 |
[The effect of monotherapy with ciprofibrate and in combination with acetylsalicylic acid on the spectrum of lipids, thromboxane and fibrinogen in patients with atherosclerosis and hyperlipoproteinemia].
Topics: Aged; Arteriosclerosis; Aspirin; Clofibric Acid; Drug Therapy, Combination; Female; Fibric Acids; Fibrinogen; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipids; Male; Middle Aged; Platelet Aggregation Inhibitors; Thromboxane B2 | 1999 |
Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists.
Topics: Abciximab; Adenosine Diphosphate; Adult; Amino Acid Substitution; Antibodies, Monoclonal; Aspirin; Blood Platelets; Cell Membrane; Dose-Response Relationship, Drug; Female; Fibrinogen; Gene Dosage; Genotype; Humans; Immunoglobulin Fab Fragments; Male; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Reference Values | 2000 |
Ex vivo--in vitro interaction between aspirin, clopidogrel, and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566A.
Topics: Abciximab; Administration, Oral; Adult; Analysis of Variance; Antibodies, Monoclonal; Aspirin; Benzylamines; Bleeding Time; Clopidogrel; Drug Administration Schedule; Drug Interactions; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Male; Nephelometry and Turbidimetry; P-Selectin; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Reference Values; Thiazoles; Ticlopidine | 2000 |
Mechanism underlying increased platelet reactivity in patients with peripheral arterial disease.
Topics: Anticoagulants; Aspirin; Blood Platelets; Fibrinogen; Heparin; Humans; Peripheral Vascular Diseases; Platelet Adhesiveness | 1999 |
Effects of acetyl salicylic acid therapy on an experimental thrombosis induced by laser beam.
Topics: Adenosine Diphosphate; Animals; Aspirin; Bleeding Time; Disease Models, Animal; Fibrinogen; Lasers; Male; Partial Thromboplastin Time; Platelet Aggregation; Rats; Rats, Wistar; Thrombosis | 2000 |
Human platelet alphaIIbeta3 integrin binding affinity and specificity of SJ874: antiplatelet efficacy versus aspirin.
Topics: Alanine; Aspirin; Bacterial Proteins; Blood Platelets; Cell Adhesion; Cell Line; DNA-Binding Proteins; Epinephrine; Fibrinogen; Fibronectins; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex | 2000 |
Echicetin, a GPIb-binding snake C-type lectin from Echis carinatus, also contains a binding site for IgMkappa responsible for platelet agglutination in plasma and inducing signal transduction.
Topics: Acetates; Animals; Aspirin; Avidin; Binding Sites; Biotinylation; Blood Proteins; Carrier Proteins; Chelating Agents; Edetic Acid; Fibrinogen; Immunoglobulin kappa-Chains; Immunoglobulin M; Lectins; Macromolecular Substances; P-Selectin; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Proteins; Signal Transduction; Tyrosine; Viper Venoms | 2001 |
Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis.
Topics: Aged; Arteriosclerosis; Ascorbic Acid; Aspirin; C-Reactive Protein; Female; Fibrinogen; Humans; Hypertension; Inflammation; Lipids; Male; Middle Aged; Multivariate Analysis; Peripheral Vascular Diseases; Severity of Illness Index; Smoking | 2001 |
Platelet aggregability under shear is enhanced in patients with unstable angina pectoris who developed acute myocardial infarction.
Topics: Aged; Angina, Unstable; Anticoagulants; Aspirin; Biomarkers; Comorbidity; Coronary Thrombosis; Creatine Kinase; Creatine Kinase, MB Form; Electrocardiography; Female; Fibrinogen; Hemorheology; Heparin; Humans; Isoenzymes; Male; Middle Aged; Myocardial Infarction; Nitrates; Platelet Aggregation; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Predictive Value of Tests; Risk Factors; Stress, Mechanical | 2001 |
Clinical application of procedural platelet monitoring during percutaneous coronary intervention among patients at increased bleeding risk.
Topics: Abciximab; Adult; Aged; Aged, 80 and over; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Carotid Stenosis; Clopidogrel; Comorbidity; Coronary Artery Bypass; Drug Therapy, Combination; Female; Fibrinogen; Graft Occlusion, Vascular; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Microspheres; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Risk; Stents; Ticlopidine | 2001 |
Modified clotting properties of fibrinogen in the presence of acetylsalicylic acid in a purified system.
Topics: Aspirin; Blood Coagulation; Fibrinogen; Humans | 2001 |
Blood coagulation at the site of microvascular injury: effects of low-dose aspirin.
Topics: Adult; Aspirin; Bleeding Time; Blood Coagulation; Blotting, Western; Factor XIII; Fibrinogen; Humans; Kinetics; Male; Platelet Aggregation Inhibitors; Platelet Count; Prothrombin; Prothrombin Time; Reference Values; Thrombin; Wounds and Injuries | 2001 |
An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregates.
Topics: Abciximab; Adenosine Diphosphate; Antibodies, Monoclonal; Aspirin; Blood Platelets; Dose-Response Relationship, Drug; Drug Synergism; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Kinetics; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding | 2002 |
[Aspirin and inflammatory markers in patients with coronary disease].
Topics: Aspirin; Biomarkers; C-Reactive Protein; Coronary Disease; Fibrinogen; Humans; Platelet Aggregation Inhibitors | 2003 |
Integrin alpha IIb beta 3-dependent calcium signals regulate platelet-fibrinogen interactions under flow. Involvement of phospholipase C gamma 2.
Topics: Animals; Apyrase; Aspirin; Blood Platelets; Calcium Signaling; Fibrinogen; Humans; Kinetics; Mice; Mice, Knockout; Phospholipase C gamma; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Type C Phospholipases | 2003 |
Plasma fibrinogen in rheumatic fever.
Topics: Aspirin; Coagulants; Fibrinogen; Hemostatics; Humans; Plasma; Rheumatic Fever | 1957 |
TREATMENT OF RHEUMATIC FEVER: COMPARISON OF THE EFFECTS OF ASPIRIN AND PHENYLBUTAZONE.
Topics: Aspirin; Blood Sedimentation; Coagulants; Drug Therapy; Fibrinogen; Hemostatics; Humans; Phenylbutazone; Rheumatic Fever; Statistics as Topic | 1964 |
Periodontal disease and biomarkers related to cardiovascular disease.
Topics: Age Factors; Aged; Aged, 80 and over; Alcohol Drinking; Antigens, CD; Aspirin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Cohort Studies; Cross-Sectional Studies; Factor VII; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Motor Activity; Periodontal Diseases; Platelet Aggregation Inhibitors; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Smoking; Tissue Plasminogen Activator; von Willebrand Factor | 2004 |
[Migraine, inflammation, genes. New risk factors for stroke].
Topics: Adult; Arteriosclerosis; Aspirin; C-Reactive Protein; Case-Control Studies; Contraceptives, Oral; Female; Fibrinogen; Folic Acid; Humans; Hyperhomocysteinemia; Inflammation; Male; Meta-Analysis as Topic; Migraine Disorders; Risk Factors; Smoking; Stroke; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Vitamin B 12; Vitamin B 6 | 2003 |
Mechanism of activation of ADP-induced platelet aggregation under the influence of oxidatively modified fibrinogen.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Diphosphate; Aspirin; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Estrenes; Fibrinogen; Genistein; Humans; In Vitro Techniques; Oxidation-Reduction; Platelet Aggregation; Protein Kinase C; Protein-Tyrosine Kinases; Pyrrolidinones; Type C Phospholipases; Ultraviolet Rays | 2004 |
The impact of vitamin K-dependent factor depletion by warfarin on platelet-rich thrombosis after deep arterial injury.
Topics: Angioplasty; Animals; Arteries; Aspirin; Blood Coagulation Factors; Blood Platelets; Dose-Response Relationship, Drug; Fibrinogen; International Normalized Ratio; Platelet Adhesiveness; Swine; Thrombosis; Vitamin K; Warfarin | 2004 |
An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease.
Topics: Abciximab; Adult; Aged; Angina, Unstable; Antibodies, Monoclonal; Anticoagulants; Aspirin; C-Reactive Protein; Case-Control Studies; Cohort Studies; Coronary Disease; Dalteparin; Female; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Inflammation Mediators; Interleukin-6; Kinetics; Male; Middle Aged; Multicenter Studies as Topic; Myocardium; Prospective Studies; Randomized Controlled Trials as Topic; Troponin T | 2005 |
Experimental study on anticoagulant and antiplatelet aggregation activity of a chemically sulfated marine polysaccharide YCP.
Topics: Animals; Antibodies; Anticoagulants; Aspirin; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Chromatography, Gel; Dose-Response Relationship, Drug; Factor Xa; Fibrin; Fibrinogen; Formamides; Fungi; In Vitro Techniques; Magnetic Resonance Spectroscopy; Models, Chemical; Molecular Weight; Partial Thromboplastin Time; Platelet Aggregation; Polysaccharides; Prothrombin Time; Pyridines; Rabbits; Spectroscopy, Fourier Transform Infrared; Sulfates; Sulfonic Acids; Sulfuric Acid Esters; Thrombin; Thrombin Time | 2005 |
Marked increase of fibrin gel permeability with very low dose ASA treatment.
Topics: Adult; Aspirin; Blood Coagulation Tests; Cross-Over Studies; Dose-Response Relationship, Drug; Fibrin; Fibrinogen; Fibrinolytic Agents; Gels; Humans; Imaging, Three-Dimensional; Male; Microscopy, Confocal; Permeability; Platelet Aggregation Inhibitors; Porosity; Time Factors | 2005 |
Platelet aggregation in portal hypertension and its modification by ultra-low doses of aspirin.
Topics: Adenosine Diphosphate; Animals; Aspirin; Fibrinogen; Hemorrhage; Humans; Hypertension, Portal; Injections, Subcutaneous; Male; Partial Thromboplastin Time; Platelet Aggregation; Platelet Aggregation Inhibitors; Prothrombin Time; Rats; Rats, Wistar | 2005 |
The platelet inhibiting effect of a clopidogrel bolus dose in patients on long-term acetylsalicylic acid treatment.
Topics: Aged; Aspirin; Blood Coagulation Tests; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fibrinogen; Flow Cytometry; Humans; Male; Middle Aged; P-Selectin; Platelet Aggregation Inhibitors; Protein Binding; Reference Values; Thrombelastography; Ticlopidine; Time Factors | 2007 |
Comparison of a rapid platelet function assay--Verify Now Aspirin--with whole blood impedance aggregometry for the detection of aspirin resistance.
Topics: Adult; Aged; Arachidonic Acid; Aspirin; Drug Resistance; Electric Impedance; Female; Fibrinogen; Humans; Male; Microspheres; Middle Aged; Photometry; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Point-of-Care Systems | 2007 |
Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling.
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Drug Therapy, Combination; Fibrinogen; Humans; Integrin alpha2beta1; Nitric Oxide; Oxidative Stress; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Pravastatin; Scavenger Receptors, Class E; Signal Transduction | 2007 |
Platelet activation, myocardial ischemic events and postoperative non-response to aspirin in patients undergoing major vascular surgery.
Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Myocardial Ischemia; P-Selectin; Platelet Activation; Vascular Surgical Procedures | 2007 |
A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.
Topics: Administration, Oral; Animals; Aorta; Aspirin; Bleeding Time; Blood Coagulation; Clopidogrel; Disease Models, Animal; Fibrin; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Naphthalenes; Platelet Activation; Platelet Aggregation Inhibitors; Propionates; Prosthesis Design; Receptors, Thromboxane A2, Prostaglandin H2; Stainless Steel; Stents; Swine; Thrombosis; Ticlopidine; Time Factors | 2007 |
Participation of IIb-IIIa glycoprotein in spontaneous platelet aggregation.
Topics: Antibodies, Monoclonal; Aspirin; Blood Platelets; Cardiovascular Diseases; Fibrinogen; Humans; Mutation; Peptide Fragments; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Protein Binding; von Willebrand Factor | 2007 |
Hemorheological background of acetylsalicylic acid resistance.
Topics: Aged; Anticoagulants; Aspirin; Blood Viscosity; Cerebrovascular Disorders; Erythrocyte Aggregation; Female; Fibrinogen; Heart Diseases; Hematocrit; Hemorheology; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Assessment | 2008 |
The effect of aspirin on hemorheological parameters of patients with diabetic retinopathy.
Topics: Adult; Aged; Aspirin; Blood Viscosity; Diabetic Retinopathy; Erythrocyte Aggregation; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Lasers; Male; Middle Aged; Platelet Aggregation Inhibitors | 2008 |
Effect of inhibitors of arachidonic acid conversion in platelets on thrombin-fibrinogen interaction and thrombin tolerance.
Topics: Animals; Arachidonic Acid; Aspirin; Blood Platelets; Dose-Response Relationship, Drug; Fibrinogen; Imidazoles; Male; Platelet Aggregation; Quinacrine; Rats; Thrombin | 2007 |
[Changes in coagulation hemostasis in patients after coronary bypass surgery].
Topics: Anticoagulants; Aspirin; Blood Coagulation Disorders; Coronary Artery Bypass; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Homeostasis; Humans; Male; Middle Aged; Myocardial Ischemia; Nadroparin; Protein C; Thrombin | 2008 |
Relation of platelet aggregation and fibrinogen levels to advancing age in aspirin- and thienopyridine-treated patients.
Topics: Aged; Aging; Aspirin; Clopidogrel; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine | 2008 |
Effects of acetylsalicylic acid on increase of fibrin network porosity and the consequent upregulation of fibrinolysis.
Topics: Aspirin; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Fibrin; Fibrinogen; Fibrinolysis; Gels; Humans; Permeability; Porosity; Salicylic Acid; Thrombin; Up-Regulation | 2009 |
Effects of aspirin on clot structure and fibrinolysis using a novel in vitro cellular system.
Topics: Animals; Aspirin; Blood Coagulation; CHO Cells; Cricetinae; Cricetulus; Fibrinogen; Fibrinolysis | 2009 |
Platelet activation patterns in platelet size sub-populations: differential responses to aspirin in vitro.
Topics: Acid Phosphatase; Adenosine Diphosphate; Arachidonic Acid; Aspirin; Blood Platelets; Cell Size; Cells, Cultured; Fibrinogen; Humans; Isoenzymes; P-Selectin; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Tartrate-Resistant Acid Phosphatase; Thromboxane B2; von Willebrand Factor | 2010 |
High-dose fibrinogen concentrate for haemostatic therapy of a major trauma patient with recent clopidogrel and aspirin intake.
Topics: Aspirin; Clopidogrel; Drug Interactions; Fibrinogen; Glasgow Coma Scale; Hemorrhage; Hemostatics; Humans; Injections, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Thrombelastography; Ticlopidine; Treatment Outcome; Wounds and Injuries | 2010 |
Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment.
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Aspirin; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Female; Fibrinogen; Germany; Humans; Inflammation Mediators; Leukocyte Count; Linear Models; Logistic Models; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Retrospective Studies; Risk Assessment; Risk Factors; Stents; Ticlopidine; Time Factors; Treatment Outcome | 2010 |
The prostaglandin E2 receptor EP4 is expressed by human platelets and potently inhibits platelet aggregation and thrombus formation.
Topics: Aspirin; Blood Coagulation; Blood Platelets; Calcium; Dinoprostone; Dose-Response Relationship, Drug; Fibrinogen; Fibrinolytic Agents; Flow Cytometry; Humans; Methyl Ethers; Naphthalenes; P-Selectin; Phenylbutyrates; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Prostaglandin E, EP4 Subtype; Thrombosis | 2010 |
Genetic associations between fibrinogen and cognitive performance in three Scottish cohorts.
Topics: Aged; Aging; Aspirin; Atherosclerosis; Cognition; Cognition Disorders; Cohort Studies; Cross-Sectional Studies; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Fibrinogen; Genotype; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Scotland | 2011 |
Acetylation and glycation of fibrinogen in vitro occur at specific lysine residues in a concentration dependent manner: a mass spectrometric and isotope labeling study.
Topics: Acetylation; Amino Acid Sequence; Aspirin; Fibrinogen; Fibrinolytic Agents; Glucose; Glycosylation; Isotope Labeling; Lysine; Mass Spectrometry; Molecular Sequence Data; Protein Structure, Tertiary | 2012 |
Multiple gene polymorphisms predisposing to the prothrombotic state in an adolescent with acute myocardial infarction.
Topics: Adolescent; Anticoagulants; Aspirin; Cholesterol Ester Transfer Proteins; Clopidogrel; Coronary Angiography; Electrocardiography; Fibrinogen; Genetic Predisposition to Disease; Heparin; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Myocardial Infarction; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Thrombosis; Ticlopidine | 2012 |
Relationship between acute stroke outcome, aspirin resistance, and humoral factors.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aspirin; C-Reactive Protein; Drug Resistance; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Intercellular Adhesion Molecule-1; Male; Middle Aged; P-Selectin; Platelet Function Tests; Prospective Studies; Stroke; von Willebrand Factor | 2012 |
Contact- and agonist-regulated microvesiculation of human platelets.
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Cell Shape; Cell-Derived Microparticles; Clopidogrel; Fibrinogen; Humans; Microscopy, Atomic Force; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine | 2013 |
Factors influencing multiplate whole blood impedance platelet aggregometry measurements, during aspirin treatment in acute ischemic stroke: a pilot study.
Topics: Adult; Aged; Aspirin; Blood Platelets; Brain Ischemia; C-Reactive Protein; Cholesterol, HDL; Clopidogrel; Electric Impedance; Female; Fibrinogen; Glycated Hemoglobin; Humans; Leukocyte Count; Leukocytes; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Stroke; Thromboxane B2; Ticlopidine; von Willebrand Factor | 2013 |
Impact of -455G/a polymorphism of the β-fibrinogen gene on platelet aggregation in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Female; Fibrinogen; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Risk Assessment; Ticlopidine | 2014 |
[A new technology for evaluating pharmacodynamics of antiaggregants].
Topics: Adult; Aspirin; Blood Coagulation; Clopidogrel; Cyclooxygenase 1; Fibrinogen; Healthy Volunteers; Humans; Kinetics; Male; Pentoxifylline; Platelet Aggregation Inhibitors; Precision Medicine; Receptors, Purinergic P2; Thrombelastography; Thrombin; Ticlopidine | 2014 |
Gender differences in hemorheological parameters and in in vitro platelet aggregation in acetylsalicylic acid and clopidogrel treated vascular patients.
Topics: Aged; Aspirin; Clopidogrel; Erythrocyte Aggregation; Female; Fibrinogen; Hematocrit; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Rheology; Ticlopidine | 2014 |
The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease.
Topics: Aged; Aspirin; Blood Coagulation Tests; C-Reactive Protein; Case-Control Studies; Complement C3; Coronary Artery Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Inflammation Mediators; Male; Microscopy, Confocal; Microscopy, Electron, Scanning; Middle Aged; Nephelometry and Turbidimetry; Platelet Aggregation Inhibitors; Registries; Risk Factors; Sex Factors; Time Factors | 2014 |
Predictors of high on-aspirin platelet reactivity in high-risk vascular patients treated with single or dual antiplatelet therapy.
Topics: Adenosine; Aged; Aspirin; Cerebrovascular Disorders; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Female; Fibrinogen; Humans; Male; Middle Aged; Piperazines; Platelet Activation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Predictive Value of Tests; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Secondary Prevention; Thiophenes; Ticagrelor; Ticlopidine | 2015 |
The changes in clot microstructure in patients with ischaemic stroke and the effects of therapeutic intervention: a prospective observational study.
Topics: Aged; Aged, 80 and over; Aspirin; Case-Control Studies; Cohort Studies; Elasticity; Female; Fibrinogen; Fibrinolytic Agents; Fractals; Humans; Male; Middle Aged; Prospective Studies; Stroke; Thrombosis; Tissue Plasminogen Activator; Whole Blood Coagulation Time | 2015 |
Activated Hemostatic Biomarkers in Patients with Implanted Left Ventricle Assist Devices: Are Heparin and/or Clopidogrel Justified?
Topics: Adult; Anticoagulants; Aspirin; Biomarkers; Clopidogrel; Drug Therapy, Combination; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Failure; Heart Ventricles; Heart-Assist Devices; Heparin; Humans; Male; Platelet Activation; Platelet Aggregation; Ticlopidine; Warfarin | 2015 |
Preventive Effect of Aspirin Eugenol Ester on Thrombosis in κ-Carrageenan-Induced Rat Tail Thrombosis Model.
Topics: Adenosine Diphosphate; Animals; Aspirin; Blood Platelets; Carrageenan; Disease Models, Animal; Erythrocyte Count; Erythrocytes; Eugenol; Fibrinogen; Hemoglobins; Male; Platelet Aggregation Inhibitors; Platelet Count; Prothrombin Time; Rats; Rats, Wistar; Thrombosis | 2015 |
Platelet reactivity in thromboelastometry. Revision of the FIBTEM test: a basic study.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acid; Aspirin; Blood Coagulation Tests; Blood Platelets; Collagen; Cytochalasin D; Female; Fibrin; Fibrinogen; Humans; Integrin beta3; Male; Oligopeptides; Platelet Activation; Platelet Aggregation; Platelet Membrane Glycoprotein IIb; Primary Cell Culture; Thrombelastography | 2017 |
Multiplate
Topics: Aged; Aged, 80 and over; Aspirin; ATP Binding Cassette Transporter, Subfamily B; Carotid Arteries; Cluster Analysis; Cyclooxygenase 1; Endarterectomy, Carotid; Female; Fibrinogen; Genomics; Hematocrit; Humans; Integrin alpha2; Integrin beta1; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Receptors, Adrenergic, alpha-2; Receptors, Cell Surface; Receptors, Thromboxane A2, Prostaglandin H2; Sequence Analysis, DNA | 2018 |
Scoring system to predict early carotid restenosis after eversion endarterectomy by analysis of inflammatory markers.
Topics: Aged; Algorithms; Aspirin; Biomarkers; C-Reactive Protein; Cardiovascular Agents; Carotid Stenosis; Clinical Decision-Making; Complement C3; Computed Tomography Angiography; Databases, Factual; Decision Support Techniques; Endarterectomy, Carotid; Female; Fibrinogen; Humans; Inflammation Mediators; Male; Middle Aged; Predictive Value of Tests; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Color | 2018 |
Is a variability of platelet inhibitory effect of anti-platelet agents important for predicting new lesion in atherothrombotic stroke?
Topics: Aged; Aged, 80 and over; Aspirin; Atherosclerosis; Blood Platelets; Clopidogrel; Diffusion Magnetic Resonance Imaging; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Thrombosis | 2018 |
Molecular mechanisms of platelet activation and aggregation induced by breast cancer cells.
Topics: Amino Acid Chloromethyl Ketones; Aspirin; Blood Platelets; Breast Neoplasms; Caco-2 Cells; Calcium Chloride; Colorectal Neoplasms; Female; Fibrin; Fibrinogen; Humans; Integrin alpha2; MCF-7 Cells; Platelet Activation; Platelet Aggregation; Thromboxane A2; Type C Phospholipases | 2018 |
Successful Pregnancy under Fibrinogen Substitution with Heparin and Aspirin in a Woman with Dysfibrinogenemia Revealed by Placental Abruption.
Topics: Abruptio Placentae; Afibrinogenemia; Aspirin; Cesarean Section; Consanguinity; Female; Fibrinogen; Genotype; Heparin, Low-Molecular-Weight; Humans; Mutation; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Thrombin Time; Young Adult | 2018 |
Unexpected low expression of platelet fibrinogen receptor in patients with chronic myeloproliferative neoplasms: how does it change with aspirin?
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Platelets; Chronic Disease; Fibrinogen; Humans; Middle Aged; Myeloproliferative Disorders | 2020 |
Exploration in the mechanism of rhubarb for the treatment of hyperviscosity syndrome based on network pharmacology.
Topics: Animals; Aspirin; Blood Platelets; Blood Viscosity; Disease Models, Animal; Fibrinogen; Hematologic Diseases; Male; Plant Extracts; Platelet Aggregation; Platelet Aggregation Inhibitors; Prothrombin; Rats, Sprague-Dawley; Rheum; Signal Transduction; Syndrome; Systems Biology | 2020 |
Supplemental Fibrinogen Restores Platelet Inhibitor-Induced Reduction in Thrombus Formation without Altering Platelet Function: An In Vitro Study.
Topics: Aged; Aspirin; Calcium Signaling; Female; Fibrinogen; Hemorheology; Heparin; Hirudins; Humans; In Vitro Techniques; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Thrombosis; Ticagrelor; Tirofiban | 2020 |
Successful management of COVID-19 and associated coagulopathy in a patient with durable left ventricular assist device.
Topics: Adult; Anticoagulants; Aspirin; Biomarkers; Blood Transfusion; COVID-19; Cytokine Release Syndrome; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart-Assist Devices; Hematoma; Hematuria; Hemorrhage; Heparin; Humans; Male; Platelet Aggregation Inhibitors; Retroperitoneal Space; Thrombocytopenia; Thrombosis | 2020 |
Antioxidant prevents clearance of hemostatically competent platelets after long-term cold storage.
Topics: Acetylcysteine; Animals; Antioxidants; Aspirin; Bleeding Time; Blood Platelets; Blood Preservation; Cell Shape; Cold Temperature; Fibrinogen; Humans; Macrophages; Mice; Mice, Inbred NOD; Mice, SCID; Mitochondria; Oxygen Consumption; Phagocytosis; Platelet Activation; Platelet Transfusion; Platelet-Rich Plasma; Reactive Oxygen Species; Thrombocytopenia | 2021 |
Glycation and acetylation sites on fibrinogen in plasma fibrin clot of patients with type 2 diabetes: Effects of low-dose acetylsalicylic acid.
Topics: Acetylation; Aspirin; Diabetes Mellitus, Type 2; Fibrin; Fibrinogen; Fibrinolysis; Humans; Proteomics | 2021 |
Preoperative Thrombocytosis is Not Associated with Overall Survival in 309 Glioblastoma Patients.
Topics: Aspirin; Brain Neoplasms; Fibrinogen; Glioblastoma; Humans; Prognosis; Retrospective Studies; Thrombocytosis | 2022 |
The impact of high on-treatment platelet reactivity and fibrinogen levels on ischemic events in patients with ST elevation myocardial infarction: a prospective observational study.
Topics: Adenosine; Aspirin; Clopidogrel; Fibrinogen; Humans; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Ticagrelor; Ticlopidine; Treatment Outcome | 2023 |
Effect of pathological high shear exposure time on platelet activation and aggregation.
Topics: Aspirin; Blood Platelets; Constriction, Pathologic; Fibrinogen; Humans; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticagrelor; Tirofiban; von Willebrand Factor | 2023 |
Aspirin and immunotherapy: a Faustian bargain?
Topics: Aspirin; Carcinoma, Hepatocellular; Fibrinogen; Humans; Immunotherapy; Liver Neoplasms | 2023 |